Target,Type,Compound,Smiles,Species,Action,Value,Parameter
dopamine_d1,agonists,A77636,NCC1OC(Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3,Hs,Full agonist,8.7,pKi
dopamine_d1,agonists,SKF-75670,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)O)O,Rn,Full agonist,8.7,pKi
dopamine_d1,agonists,SKF-81297,Oc1c(O)cc2c(c1Cl)CCNCC2c1ccccc1,Rn,Full agonist,8.7,pKi
dopamine_d1,agonists,tavapadon,CC1=C(C=CC(=C1)OC2=NC=CC=C2C(F)(F)F)C3=C(C)C(=O)NC(=O)N3C,Hs,Partial agonist,8.1,pKi
dopamine_d1,agonists,dihydrexidine,Oc1cc2CCC3C(c2cc1O)c1ccccc1CN3,Rn,Full agonist,8.0,pKi
dopamine_d1,agonists,(+)-SKF-82526,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Full agonist,7.6,pKi
dopamine_d1,agonists,N-propylnorapomorphine,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Full agonist,7.4,pKi
dopamine_d1,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,7.2,pKi
dopamine_d1,agonists,fenoldopam,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Full agonist,6.5 – 7.9,pKi
dopamine_d1,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,6.7,pKi
dopamine_d1,agonists,SKF-38393,Oc1cc2CCNCC(c2cc1O)c1ccccc1,Hs,Partial agonist,6.2 – 6.8,pKi
dopamine_d1,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,6.2,pKi
dopamine_d1,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,5.9 – 6.5,pKi
dopamine_d1,agonists,SKF-76783,,Hs,Full agonist,6.2,pKi
dopamine_d1,agonists,(+)-ADTN,NC1CCc2c(C1)cc(c(c2)O)O,Hs,Full agonist,5.3 – 6.4,pKi
dopamine_d1,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Full agonist,5.3 – 6.2,pKi
dopamine_d1,agonists,(-)-SKF-82526,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Partial agonist,5.7,pKi
dopamine_d1,agonists,rotigotine,CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1,Hs,Full agonist,5.6,pKi
dopamine_d1,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Partial agonist,5.0,pKi
dopamine_d1,agonists,dopamine,NCCc1ccc(c(c1)O)O,Hs,Full agonist,4.3 – 5.6,pKi
dopamine_d1,agonists,noradrenaline,NCC(c1ccc(c(c1)O)O)O,Hs,Full agonist,4.3,pKi
dopamine_d1,agonists,SKF-83959,CN1CCc2c(C(C1)c1cccc(c1)C)cc(c(c2Cl)O)O,Hs,Biased agonist,9.7,pEC50
dopamine_d1,agonists,A68930,NCC1OC(Cc2c1ccc(c2O)O)c1ccccc1,Hs,Agonist,6.8,pEC50
dopamine_d1,agonists,SKF-82958,C=CCN1CCc2c(C(C1)c1ccccc1)cc(c(c2Cl)O)O,Hs,Agonist,-,-
dopamine_d1,antagonists,[125I]SCH23982,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)I)O,Hs,Antagonist,9.5,pKd
dopamine_d1,antagonists,[3H]SCH-23390,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O,Hs,Antagonist,9.5,pKd
dopamine_d1,antagonists,SKF-83566,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Br)O,Hs,Antagonist,9.5,pKi
dopamine_d1,antagonists,SCH-23390,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O,Hs,Antagonist,7.4 – 9.5,pKi
dopamine_d1,antagonists,ecopipam,CN1CCc2c(C3C1CCc1c3cccc1)cc(c(c2)Cl)O,Hs,Antagonist,8.3,pKi
dopamine_d1,antagonists,periciazine,N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1,Hs,Antagonist,8.0,pKi
dopamine_d1,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,7.6 – 8.2,pKi
dopamine_d1,antagonists,fluphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.7,pKi
dopamine_d1,antagonists,flupentixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.0 – 8.4,pKi
dopamine_d1,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,6.5 – 8.5,pKi
dopamine_d1,antagonists,prochlorperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,7.1,pKi
dopamine_d1,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.1,pKi
dopamine_d1,antagonists,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,Hs,Antagonist,7.0,pKi
dopamine_d1,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,7.0,pKi
dopamine_d1,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,6.9,pKi
dopamine_d1,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,6.7,pKi
dopamine_d1,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,6.7,pKi
dopamine_d1,allosterics,mevidalen,OCC1Cc2c(cccc2C(N1C(=O)Cc1c(Cl)cccc1Cl)C)CCC(O)(C)C,Hs,Positive,8.6,pEC50
dopamine_d1,allosterics,LY3154885,OC[C@H]1Cc2c([C@@H](N1C(=O)Cc1c(Cl)cccc1Cl)C)cccc2c1cnn(c1)C,Hs,Positive,7.9,pEC50
dopamine_d1,allosterics,UCM-1306,FCOc1ccccc1c1ccc(cc1)S(=O)(=N)C,Hs,Positive,7.2,pEC50
dopamine_d1,allosterics,mevidalen,OCC1Cc2c(cccc2C(N1C(=O)Cc1c(Cl)cccc1Cl)C)CCC(O)(C)C,Mm,Positive,7.2,pEC50
dopamine_d2,agonists,rotigotine,CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1,Hs,Agonist,10.2,pKi
dopamine_d2,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Rn,Partial agonist,9.7,pKi
dopamine_d2,agonists,brexpiprazole,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,Hs,Partial agonist,9.5,pKi
dopamine_d2,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,9.2 – 9.5,pKi
dopamine_d2,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,9.1,pKi
dopamine_d2,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Partial agonist,9.0 – 9.2,pKi
dopamine_d2,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,9.1,pKi
dopamine_d2,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,8.6,pKi
dopamine_d2,agonists,UNC9975,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,Hs,Biased agonist,8.6,pKi
dopamine_d2,agonists,UNC0006,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,Hs,Biased agonist,8.3,pKi
dopamine_d2,agonists,cariprazine,O=C(N(C)C)NC1CCC(CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,8.2,pKi
dopamine_d2,agonists,MLS1547,Clc1cc(CN2CCN(CC2)c2ccccn2)c(c2c1cccn2)O,Hs,Biased agonist,8.2,pKi
dopamine_d2,agonists,(-)-N-porphynorapomorphine,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Full agonist,7.5 – 8.9,pKi
dopamine_d2,agonists,ropinirole,CCCN(CCC)CCc1cccc2c1CC(=N2)O,Hs,Agonist,8.1,pKi
dopamine_d2,agonists,LP-44,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2,Hs,Agonist,8.1,pKi
dopamine_d2,agonists,sumanirole,CNC1Cc2cccc3c2n(C1)c(=O)[nH]3,Hs,Full agonist,8.1,pKi
dopamine_d2,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Full agonist,7.3 – 8.3,pKi
dopamine_d2,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Rn,Partial agonist,7.6,pKi
dopamine_d2,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,7.5 – 7.6,pKi
dopamine_d2,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Rn,Partial agonist,7.3,pKi
dopamine_d2,agonists,UNC9994,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,Hs,Biased agonist,7.1,pKi
dopamine_d2,agonists,compound 3 [PMID: 23134120],Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1,Hs,Agonist,6.9,pKi
dopamine_d2,agonists,piribedil,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2,Hs,Partial agonist,6.8 – 6.9,pKi
dopamine_d2,agonists,LP-211,N#Cc1ccc(cc1)CNC(=O)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1,Hs,Agonist,6.8,pKi
dopamine_d2,agonists,LP-12,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1,Hs,Agonist,6.7,pKi
dopamine_d2,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Partial agonist,5.7 – 7.5,pKi
dopamine_d2,agonists,7-OH-DPAT,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,Hs,Full agonist,5.6 – 7.6,pKi
dopamine_d2,agonists,HS665,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1,Hs,Agonist,6.3,pKi
dopamine_d2,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,4.9 – 7.7,pKi
dopamine_d2,agonists,pramipexole,CCCNC1CCc2c(C1)sc(n2)N,Hs,Full agonist,5.1 – 7.4,pKi
dopamine_d2,agonists,7-OH-DPAT,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,Rn,Full agonist,6.2,pKi
dopamine_d2,agonists,dopamine,NCCc1ccc(c(c1)O)O,Hs,Full agonist,4.7 – 7.2,pKi
dopamine_d2,agonists,PD 128907,CCCN1CCOC2C1COc1c2cc(cc1)O,Hs,Full agonist,5.4 – 6.4,pKi
dopamine_d2,agonists,dopamine,NCCc1ccc(c(c1)O)O,Rn,Full agonist,5.3 – 6.4,pKi
dopamine_d2,agonists,7-trans-OH-PIPAT,IC=CCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.6,pKi
dopamine_d2,agonists,quinelorane,CCCN1CCCC2C1Cc1cnc(nc1C2)N,Hs,Full agonist,5.5 – 5.7,pKi
dopamine_d2,agonists,benzquinamide,CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC,Hs,Agonist,5.4,pKi
dopamine_d2,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Rn,Full agonist,5.2,pKi
dopamine_d2,agonists,UNC9975,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,Hs,Biased agonist,9.0,pEC50
dopamine_d2,agonists,UNC0006,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,Hs,Biased agonist,8.9,pEC50
dopamine_d2,agonists,UNC9994,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,Hs,Biased agonist,8.2,pEC50
dopamine_d2,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,7.4,pEC50
dopamine_d2,agonists,vilazodone,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,Hs,Agonist,6.2,pIC50
dopamine_d2,antagonists,[3H]nemonapride,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl,Hs,Antagonist,10.9,pKd
dopamine_d2,antagonists,[3H]spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Rn,Antagonist,10.2,pKd
dopamine_d2,antagonists,[3H]raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Rn,Antagonist,8.9,pKd
dopamine_d2,antagonists,[3H]N-methylspiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1,Rn,Antagonist,10.7,pKi
dopamine_d2,antagonists,benperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,10.6,pKi
dopamine_d2,antagonists,blonanserin,CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F,Hs,Antagonist,9.9,pKi
dopamine_d2,antagonists,pipotiazine,OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C,Hs,Antagonist,9.7,pKi
dopamine_d2,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,9.4,pKi
dopamine_d2,antagonists,perphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,8.9 – 9.6,pKi
dopamine_d2,antagonists,perospirone,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1CCCC2,Hs,Antagonist,9.2,pKi
dopamine_d2,antagonists,eticlopride,CCN1CCCC1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl,Hs,Antagonist,9.2,pKi
dopamine_d2,antagonists,trifluoperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,8.9 – 9.0,pKi
dopamine_d2,antagonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Antagonist,8.9,pKi
dopamine_d2,antagonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Antagonist,8.9,pKi
dopamine_d2,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Rn,Antagonist,8.4 – 9.4,pKi
dopamine_d2,antagonists,fluphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,8.8,pKi
dopamine_d2,antagonists,flupentixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,8.8,pKi
dopamine_d2,antagonists,nafadotride,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2,Rn,Antagonist,8.8,pKi
dopamine_d2,antagonists,lurasidone,O=C1N(CC2CCCCC2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1C1CCC2C1,Rn,Antagonist,8.8,pKi
dopamine_d2,antagonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Antagonist,8.7,pKi
dopamine_d2,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,8.7,pKi
dopamine_d2,antagonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Antagonist,8.6,pKi
dopamine_d2,antagonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Antagonist,8.6,pKi
dopamine_d2,antagonists,chlorprothixene,CN(CC/C=C\1/c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,8.5,pKi
dopamine_d2,antagonists,nafadotride,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2,Hs,Antagonist,8.5,pKi
dopamine_d2,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Rn,Antagonist,7.7 – 9.3,pKi
dopamine_d2,antagonists,domperidone,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2,Rn,Antagonist,8.5,pKi
dopamine_d2,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,8.0 – 8.9,pKi
dopamine_d2,antagonists,prochlorperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,8.4,pKi
dopamine_d2,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Rn,Antagonist,8.3,pKi
dopamine_d2,antagonists,(+)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,8.2,pKi
dopamine_d2,antagonists,"L-741,626",Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,Hs,Antagonist,7.9 – 8.5,pKi
dopamine_d2,antagonists,domperidone,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2,Hs,Antagonist,7.9 – 8.4,pKi
dopamine_d2,antagonists,loxapine,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2,Hs,Antagonist,7.9 – 8.3,pKi
dopamine_d2,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,7.5 – 8.7,pKi
dopamine_d2,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,7.4 – 8.8,pKi
dopamine_d2,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Hs,Antagonist,8.0,pKi
dopamine_d2,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,8.0,pKi
dopamine_d2,antagonists,(-)-stepholidine,COc1cc2CCN3C(c2cc1O)Cc1c(C3)c(OC)c(cc1)O,Hs,Antagonist,7.9,pKi
dopamine_d2,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,7.0 – 8.8,pKi
dopamine_d2,antagonists,amisulpride,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,Hs,Antagonist,7.8 – 8.0,pKi
dopamine_d2,antagonists,cinnarizine,c1ccc(cc1)C=CCN1CCN(CC1)C(c1ccccc1)c1ccccc1,Rn,Antagonist,7.9,pKi
dopamine_d2,antagonists,flunarizine,C1=CC=C(C=C1)/C=C/CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,Rn,Antagonist,6.9 – 8.4,pKi
dopamine_d2,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Rn,Antagonist,7.6,pKi
dopamine_d2,antagonists,sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,7.2 – 7.9,pKi
dopamine_d2,antagonists,metoclopramide,CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC,Mm,Antagonist,7.5,pKi
dopamine_d2,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Rn,Antagonist,7.5,pKi
dopamine_d2,antagonists,lumateperone,Fc1ccc(cc1)C(=O)CCCN1CCC2C(C1)c1cccc3c1N2CCN3C,Hs,Antagonist,7.5,pKi
dopamine_d2,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.0 – 7.6,pKi
dopamine_d2,antagonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Antagonist,7.2,pKi
dopamine_d2,antagonists,(-)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,6.3 – 8.0,pKi
dopamine_d2,antagonists,R-VK4-40,CCc1cccc(c1Cl)N1CCN(CC1)C[C@@H](CCNC(=O)c1cc2c([nH]1)cccc2)O,Hs,Antagonist,7.1,pKi
dopamine_d2,antagonists,(+)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Rn,Antagonist,7.0,pKi
dopamine_d2,antagonists,ML321,O=C(c1ccc2c(c1)N(C)C(=O)c1c(S2=O)cccc1)NCCc1cccs1,Hs,Antagonist,7.0,pKi
dopamine_d2,antagonists,trans-flupenthixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,6.9,pKi
dopamine_d2,antagonists,EGIS-11150,Fc1ccc2c(c1)onc2C1CCN(CC1)CCNc1cnn(c(=O)c1Cl)C,Hs,Antagonist,6.9,pKi
dopamine_d2,antagonists,(+)-UH232,CCCN(C1C=Cc2c(C1C)cccc2OC)CCC,Hs,Antagonist,6.4 – 7.1,pKi
dopamine_d2,antagonists,promazine,CN(CCCN1c2ccccc2Sc2c1cccc2)C,Hs,Antagonist,6.5,pKi
dopamine_d2,antagonists,(+)-UH232,CCCN(C1C=Cc2c(C1C)cccc2OC)CCC,Rn,Antagonist,6.4,pKi
dopamine_d2,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,5.8 – 6.9,pKi
dopamine_d2,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Rn,Antagonist,6.2,pKi
dopamine_d2,antagonists,(+)-S-14297,CCCN(C1CCc2c(C1)cc1c(c2)CCO1)CCC,Hs,Antagonist,5.5,pKi
dopamine_d2,antagonists,(+)-SCH-23390,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O,Hs,Antagonist,5.3,pKi
dopamine_d2,antagonists,iloperidone,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C,Rn,Antagonist,7.0,pIC50
dopamine_d2,antagonists,metopimazine,NC(=O)C1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)C,N/A,Antagonist,-,-
dopamine_d2,antagonists,alizapride,C=CCN1CCCC1CNC(=O)c1cc2[nH]nnc2cc1OC,N/A,Antagonist,-,-
dopamine_d2,allosterics,SB269652,N#Cc1ccc2c(c1)CN(CC2)CCC1CCC(CC1)NC(=O)c1cc2c([nH]1)cccc2,Hs,Negative,6.4,pKB
dopamine_d3,agonists,[3H]7-OH-DPAT,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,Hs,Agonist,9.6,pKd
dopamine_d3,agonists,[3H]7-OH-DPAT,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,Rn,Agonist,9.1,pKd
dopamine_d3,agonists,[3H]PD128907,CCCN1CCOC2C1COc1c2cc(cc1)O,Hs,Agonist,9.0,pKd
dopamine_d3,agonists,cariprazine,O=C(N(C)C)NC1CCC(CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,10.1,pKi
dopamine_d3,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,9.6,pKi
dopamine_d3,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Partial agonist,9.1,pKi
dopamine_d3,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,9.0,pKi
dopamine_d3,agonists,BP 897,COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2,Hs,Partial agonist,9.0,pKi
dopamine_d3,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,8.9,pKi
dopamine_d3,agonists,pramipexole,CCCNC1CCc2c(C1)sc(n2)N,Hs,Full agonist,8.4 – 8.7,pKi
dopamine_d3,agonists,(-)-N-porphynorapomorphine,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Full agonist,8.4 – 8.7,pKi
dopamine_d3,agonists,rotigotine,CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1,Hs,Agonist,8.4,pKi
dopamine_d3,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Partial agonist,8.3,pKi
dopamine_d3,agonists,7-OH-DPAT,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,Hs,Full agonist,7.1 – 8.4,pKi
dopamine_d3,agonists,ropinirole,CCCN(CCC)CCc1cccc2c1CC(=N2)O,Hs,Agonist,7.7,pKi
dopamine_d3,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Rn,Partial agonist,7.7,pKi
dopamine_d3,agonists,7-trans-OH-PIPAT,IC=CCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,7.7,pKi
dopamine_d3,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,7.1 – 8.2,pKi
dopamine_d3,agonists,PD 128907,CCCN1CCOC2C1COc1c2cc(cc1)O,Hs,Full agonist,7.6 – 7.7,pKi
dopamine_d3,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Rn,Full agonist,7.3 – 7.8,pKi
dopamine_d3,agonists,quinelorane,CCCN1CCCC2C1Cc1cnc(nc1C2)N,Hs,Full agonist,7.2 – 7.4,pKi
dopamine_d3,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,6.4 – 8.0,pKi
dopamine_d3,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Rn,Full agonist,7.1,pKi
dopamine_d3,agonists,dopamine,NCCc1ccc(c(c1)O)O,Hs,Full agonist,6.4 – 7.3,pKi
dopamine_d3,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Partial agonist,6.1 – 7.6,pKi
dopamine_d3,agonists,compound 3 [PMID: 23134120],Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1,Hs,Agonist,6.8,pKi
dopamine_d3,agonists,piribedil,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2,Hs,Partial agonist,6.6,pKi
dopamine_d3,agonists,HS665,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1,Hs,Agonist,6.6,pKi
dopamine_d3,agonists,vilazodone,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,Hs,Agonist,7.2,pIC50
dopamine_d3,agonists,PF-592379,CCCN1CC(OCC1C)c1ccc(nc1)N,Hs,Agonist,6.7,pIC50
dopamine_d3,antagonists,[3H]nemonapride,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl,Hs,Antagonist,10.3,pKd
dopamine_d3,antagonists,[3H]spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Rn,Antagonist,9.9,pKd
dopamine_d3,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,9.6,pKi
dopamine_d3,antagonists,perospirone,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1CCCC2,Hs,Antagonist,9.6,pKi
dopamine_d3,antagonists,R-VK4-40,CCc1cccc(c1Cl)N1CCN(CC1)C[C@@H](CCNC(=O)c1cc2c([nH]1)cccc2)O,Hs,Antagonist,9.5,pKi
dopamine_d3,antagonists,nafadotride,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2,Hs,Antagonist,9.5,pKi
dopamine_d3,antagonists,nemonapride,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl,Hs,Antagonist,9.2 – 9.3,pKi
dopamine_d3,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,9.2,pKi
dopamine_d3,antagonists,PG01037,O=C(c1ccc(cc1)c1ccccn1)NCC=CCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Antagonist,9.2,pKi
dopamine_d3,antagonists,flupentixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,9.0,pKi
dopamine_d3,antagonists,eticlopride,CCN1CCCC1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl,Hs,Antagonist,8.8,pKi
dopamine_d3,antagonists,NGB 2904,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Antagonist,8.8,pKi
dopamine_d3,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,8.0 – 8.8,pKi
dopamine_d3,antagonists,prochlorperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,8.4,pKi
dopamine_d3,antagonists,chlorprothixene,CN(CC/C=C\1/c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,8.3,pKi
dopamine_d3,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,8.2,pKi
dopamine_d3,antagonists,(+)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,8.1,pKi
dopamine_d3,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,7.5 – 8.6,pKi
dopamine_d3,antagonists,SB 277011-A,N#Cc1ccc2c(c1)CCN(C2)CCC1CCC(CC1)NC(=O)c1ccnc2c1cccc2,Hs,Antagonist,8.0,pKi
dopamine_d3,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Hs,Antagonist,7.9,pKi
dopamine_d3,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,7.0 – 8.6,pKi
dopamine_d3,antagonists,loxapine,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2,Hs,Antagonist,7.7,pKi
dopamine_d3,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,7.6,pKi
dopamine_d3,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Rn,Antagonist,7.5,pKi
dopamine_d3,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Rn,Antagonist,7.3 – 7.5,pKi
dopamine_d3,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Rn,Antagonist,7.4,pKi
dopamine_d3,antagonists,amisulpride,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,Rn,Antagonist,7.4,pKi
dopamine_d3,antagonists,(+)-S-14297,CCCN(C1CCc2c(C1)cc1c(c2)CCO1)CCC,Hs,Antagonist,6.9 – 7.9,pKi
dopamine_d3,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,6.7 – 8.0,pKi
dopamine_d3,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.2 – 7.5,pKi
dopamine_d3,antagonists,domperidone,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2,Hs,Antagonist,7.1 – 7.6,pKi
dopamine_d3,antagonists,sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,6.8 – 7.8,pKi
dopamine_d3,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Rn,Antagonist,7.2,pKi
dopamine_d3,antagonists,(+)-UH232,CCCN(C1C=Cc2c(C1C)cccc2OC)CCC,Hs,Antagonist,7.0 – 7.4,pKi
dopamine_d3,antagonists,(-)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,6.7 – 7.7,pKi
dopamine_d3,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Rn,Antagonist,7.0,pKi
dopamine_d3,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,7.0,pKi
dopamine_d3,antagonists,(+)-UH232,CCCN(C1C=Cc2c(C1C)cccc2OC)CCC,Rn,Antagonist,7.0,pKi
dopamine_d3,antagonists,domperidone,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2,Rn,Antagonist,7.0,pKi
dopamine_d3,antagonists,promazine,CN(CCCN1c2ccccc2Sc2c1cccc2)C,Hs,Antagonist,6.8,pKi
dopamine_d3,antagonists,trans-flupenthixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,6.5,pKi
dopamine_d3,antagonists,(+)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Rn,Antagonist,6.4,pKi
dopamine_d3,antagonists,(+)-AJ76,CCCNC1CCc2c(C1C)cccc2OC,Hs,Antagonist,5.9 – 6.2,pKi
dopamine_d3,antagonists,(+)-AJ76,CCCNC1CCc2c(C1C)cccc2OC,Rn,Antagonist,6.0,pKi
dopamine_d3,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,5.2 – 6.3,pKi
dopamine_d3,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Rn,Antagonist,5.7,pKi
dopamine_d3,allosterics,SB269652,N#Cc1ccc2c(c1)CN(CC2)CCC1CCC(CC1)NC(=O)c1cc2c([nH]1)cccc2,Hs,Negative,~9.0,pKi
dopamine_d4,agonists,CP-226269,Fc1ccc2c(c1)cc([nH]2)CN1CCN(CC1)c1ccccn1,Rn,Partial agonist,9.4,pKi
dopamine_d4,agonists,FAUC213,Clc1ccc(cc1)N1CCN(CC1)Cc1cc2n(n1)cccc2,Rn,Partial agonist,9.0,pKi
dopamine_d4,agonists,"PD168,077",N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C,Rn,Partial agonist,8.8,pKi
dopamine_d4,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Partial agonist,8.4,pKi
dopamine_d4,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,8.3,pKi
dopamine_d4,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,8.2,pKi
dopamine_d4,agonists,A412997,O=C(Nc1cccc(c1)C)CN1CCC(CC1)c1ccccn1,Rn,Agonist,8.1,pKi
dopamine_d4,agonists,A412997,O=C(Nc1cccc(c1)C)CN1CCC(CC1)c1ccccn1,Hs,Full agonist,8.1,pKi
dopamine_d4,agonists,WAY-100635,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1,Hs,Full agonist,7.8,pKi
dopamine_d4,agonists,dopamine,NCCc1ccc(c(c1)O)O,Hs,Full agonist,7.6,pKi
dopamine_d4,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,7.5,pKi
dopamine_d4,agonists,dopamine,NCCc1ccc(c(c1)O)O,Rn,Full agonist,7.4,pKi
dopamine_d4,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Partial agonist,7.3,pKi
dopamine_d4,agonists,rotigotine,CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1,Hs,Agonist,7.3,pKi
dopamine_d4,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Partial agonist,7.2,pKi
dopamine_d4,agonists,fenoldopam,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Full agonist,6.5,pKi
dopamine_d4,agonists,ABT-670,Cc1cccc(c1)C(=O)NCN1CCC(CC1)c1cccc[n+]1[O-],Hs,Full agonist,5.8,pKi
dopamine_d4,agonists,PF-592379,CCCN1CC(OCC1C)c1ccc(nc1)N,Hs,Agonist,5.4,pIC50
dopamine_d4,antagonists,nemonapride,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl,Hs,Antagonist,10.0,pKd
dopamine_d4,antagonists,[125I]L750667,Ic1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2,Hs,Antagonist,9.8,pKd
dopamine_d4,antagonists,[3H]spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,9.5,pKd
dopamine_d4,antagonists,[3H]NGD941,c1ccc(cc1)c1ncc([nH]1)CN1CCN(CC1)c1ncccn1,Hs,Antagonist,8.3,pKd
dopamine_d4,antagonists,benperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,10.2,pKi
dopamine_d4,antagonists,perospirone,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1CCCC2,Hs,Antagonist,10.1,pKi
dopamine_d4,antagonists,"L-750,667",Ic1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2,Rn,Antagonist,10.0,pKi
dopamine_d4,antagonists,RBI257,CC(Oc1cccnc1N(C1CCN(CC1)Cc1ccc(cc1)I)C)C,Rn,Antagonist,9.6,pKi
dopamine_d4,antagonists,[3H]N-methylspiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1,Rn,Antagonist,9.5,pKi
dopamine_d4,antagonists,CP-293019,Fc1ccc(cc1)OCC1CCC2N(C1)CCN(C2)c1ncc(cn1)F,Rn,Antagonist,9.5,pKi
dopamine_d4,antagonists,NGD 94-1,c1ccc(cc1)c1ncc([nH]1)CN1CCN(CC1)c1ncccn1,Rn,Antagonist,9.5,pKi
dopamine_d4,antagonists,L745870,Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2,Hs,Antagonist,9.4,pKi
dopamine_d4,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,9.3,pKi
dopamine_d4,antagonists,FAUC213,Clc1ccc(cc1)N1CCN(CC1)Cc1cc2n(n1)cccc2,Rn,Antagonist,9.0,pKi
dopamine_d4,antagonists,sonepiprazole,NS(=O)(=O)c1ccc(cc1)N1CCN(CC1)CCC1OCCc2c1cccc2,Hs,Antagonist,8.9,pKi
dopamine_d4,antagonists,U101958,CC(Oc1cccnc1N(C1CCN(CC1)Cc1ccccc1)C)C,Hs,Antagonist,8.9,pKi
dopamine_d4,antagonists,A-381393,Cc1ccc(cc1C)N1CCN(CC1)Cc1nc2c([nH]1)cccc2,Hs,Antagonist,8.8,pKi
dopamine_d4,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,8.7 – 8.8,pKi
dopamine_d4,antagonists,sonepiprazole,NS(=O)(=O)c1ccc(cc1)N1CCN(CC1)CCC1OCCc2c1cccc2,Rn,Antagonist,8.7,pKi
dopamine_d4,antagonists,L741742,Clc1ccc(cc1)c1onc(c1C)C1CCN(CC1)CCc1ccccc1,Hs,Antagonist,8.5,pKi
dopamine_d4,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,7.8 – 9.1,pKi
dopamine_d4,antagonists,loxapine,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2,Hs,Antagonist,8.1,pKi
dopamine_d4,antagonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Antagonist,8.1,pKi
dopamine_d4,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.8,pKi
dopamine_d4,antagonists,Ro 10-4548,COc1cc(ccc1O)N1CCN(CC1)CC(COc1ccccc1NC(=O)C)O,Rn,Antagonist,7.8,pKi
dopamine_d4,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,7.5,pKi
dopamine_d4,antagonists,ML398,Clc1ccc(cc1)CN1CCOC(C1)CCc1ccccc1,Hs,Antagonist,7.4,pKi
dopamine_d4,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.4,pKi
dopamine_d4,antagonists,trifluoperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.4,pKi
dopamine_d4,antagonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Rn,Antagonist,7.3,pKi
dopamine_d4,antagonists,eticlopride,CCN1CCCC1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl,Hs,Antagonist,7.0,pKi
dopamine_d4,antagonists,(-)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,5.7 – 7.7,pKi
dopamine_d4,antagonists,piribedil,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2,Hs,Antagonist,6.5,pKi
dopamine_d4,antagonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Antagonist,6.4,pKi
dopamine_d4,antagonists,nafadotride,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2,Rn,Antagonist,6.4,pKi
dopamine_d4,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,6.3,pKi
dopamine_d4,antagonists,prochlorperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,6.1,pKi
dopamine_d4,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Rn,Antagonist,5.7,pKi
dopamine_d4,antagonists,(+)-sulpiride,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,Hs,Antagonist,5.7,pKi
dopamine_d5,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,8.5,pKi
dopamine_d5,agonists,(+)-SKF-82526,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Full agonist,7.8,pKi
dopamine_d5,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,7.7,pKi
dopamine_d5,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Partial agonist,6.4 – 7.8,pKi
dopamine_d5,agonists,SKF-38393,Oc1cc2CCNCC(c2cc1O)c1ccccc1,Hs,Partial agonist,7.0,pKi
dopamine_d5,agonists,beta-ergocriptine,CCC(C1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C,Hs,Full agonist,6.9,pKi
dopamine_d5,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,6.0 – 7.5,pKi
dopamine_d5,agonists,dopamine,NCCc1ccc(c(c1)O)O,Hs,Full agonist,6.6,pKi
dopamine_d5,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Full agonist,6.3,pKi
dopamine_d5,agonists,SKF-76783,,Hs,Full agonist,6.3,pKi
dopamine_d5,agonists,(-)-SKF-82526,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,Hs,Full agonist,6.1,pKi
dopamine_d5,agonists,(+)-ADTN,NC1CCc2c(C1)cc(c(c2)O)O,Hs,Full agonist,6.0,pKi
dopamine_d5,agonists,rotigotine,CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1,Hs,Full agonist,6.0,pKi
dopamine_d5,agonists,N-propylnorapomorphine,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Full agonist,5.9,pKi
dopamine_d5,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,5.5,pKi
dopamine_d5,agonists,noradrenaline,NCC(c1ccc(c(c1)O)O)O,Hs,Full agonist,4.9,pKi
dopamine_d5,agonists,A68930,NCC1OC(Cc2c1ccc(c2O)O)c1ccccc1,Hs,Agonist,6.6,pEC50
dopamine_d5,antagonists,[3H]SCH-23390,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O,Hs,Antagonist,9.2,pKd
dopamine_d5,antagonists,SKF-83566,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Br)O,Hs,Antagonist,9.4,pKi
dopamine_d5,antagonists,SCH-23390,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O,Hs,Antagonist,7.5 – 9.5,pKi
dopamine_d5,antagonists,ecopipam,CN1CCc2c(C3C1CCc1c3cccc1)cc(c(c2)Cl)O,Hs,Antagonist,8.3,pKi
dopamine_d5,antagonists,flupentixol,OCCN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,8.1,pKi
dopamine_d5,antagonists,fluphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.9,pKi
dopamine_d5,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,7.6,pKi
dopamine_d5,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,6.9,pKi
dopamine_d5,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,6.6,pKi
dopamine_d5,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,6.3,pKi
dopamine_d5,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,5.6,pKi
dopamine_d5,antagonists,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,Hs,Antagonist,5.6,pKi
dopamine_d5,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.3,pKi
serotonin_5ht1a,agonists,[3H]NLX-112,Cc1ccc(nc1)CNCC1(F)CCN(CC1)C(=O)c1ccc(c(c1)Cl)F,Hs,Full agonist,8.9,pKd
serotonin_5ht1a,agonists,[3H]8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,6.0 – 9.4,pKd
serotonin_5ht1a,agonists,[3H]S-15535,C1COc2c(O1)cccc2N1CCN(CC1)C1Cc2c(C1)cccc2,Hs,Partial agonist,5.8 – 5.9,pKd
serotonin_5ht1a,agonists,S-14671,COc1ccc2c(c1)c(ccc2)N1CCN(CC1)CCNC(=O)c1cccs1,Hs,Full agonist,10.2 – 10.5,pKi
serotonin_5ht1a,agonists,LY293284,CCCN(C1Cc2c[nH]c3c2c(C1)c(cc3)C(=O)C)CCC,Hs,Full agonist,10.1,pKi
serotonin_5ht1a,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,9.4 – 10.3,pKi
serotonin_5ht1a,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,9.7 – 9.8,pKi
serotonin_5ht1a,agonists,U92016A,CCCN(C1CCc2c(C1)c1cc([nH]c1cc2)C#N)CCC,Hs,Full agonist,9.7,pKi
serotonin_5ht1a,agonists,vilazodone,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,Hs,Partial agonist,9.7,pKi
serotonin_5ht1a,agonists,S-14506,COc1ccc2c(c1)c(ccc2)N1CCN(CC1)CCNC(=O)c1ccc(cc1)F,Hs,Full agonist,9.6 – 9.7,pKi
serotonin_5ht1a,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,9.4 – 9.9,pKi
serotonin_5ht1a,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,9.1 – 9.7,pKi
serotonin_5ht1a,agonists,flesinoxan,OCC1COc2c(O1)cccc2N1CCN(CC1)CCNC(=O)c1ccc(cc1)F,Hs,Full agonist,9.3,pKi
serotonin_5ht1a,agonists,"L-694,247",NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C,Hs,Full agonist,9.3,pKi
serotonin_5ht1a,agonists,S-15535,C1COc2c(O1)cccc2N1CCN(CC1)C1Cc2c(C1)cccc2,Hs,Partial agonist,9.2,pKi
serotonin_5ht1a,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,9.0,pKi
serotonin_5ht1a,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,9.0,pKi
serotonin_5ht1a,agonists,flibanserin,O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2,Hs,Agonist,9.0,pKi
serotonin_5ht1a,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,8.4 – 9.4,pKi
serotonin_5ht1a,agonists,"LY 165,163",Nc1ccc(cc1)CCN1CCN(CC1)c1cccc(c1)C(F)(F)F,Hs,Full agonist,8.9,pKi
serotonin_5ht1a,agonists,spiroxatrine,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1,Hs,Full agonist,8.8,pKi
serotonin_5ht1a,agonists,ipsapirone,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1,Hs,Partial agonist,8.6 – 8.8,pKi
serotonin_5ht1a,agonists,FG-5893,COC(=O)c1cccnc1N1CCN(CC1)CCCC(c1ccc(cc1)F)c1ccc(cc1)F,Hs,Full agonist,8.7,pKi
serotonin_5ht1a,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Partial agonist,8.7,pKi
serotonin_5ht1a,agonists,7-methoxy-1-naphthylpiperazine,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C,Hs,Full agonist,8.6,pKi
serotonin_5ht1a,agonists,(R)-UH 301,CCCN(C1CCc2c(C1)c(O)ccc2F)CCC,Hs,Partial agonist,8.6,pKi
serotonin_5ht1a,agonists,NLX-101,Cc1cnc(nc1)CNCC1(F)CCN(CC1)C(=O)c1ccc(c(c1)Cl)F,Hs,Full agonist,8.6,pKi
serotonin_5ht1a,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,8.5,pKi
serotonin_5ht1a,agonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Partial agonist,7.9 – 8.9,pKi
serotonin_5ht1a,agonists,S 16924,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2,Hs,Partial agonist,8.4,pKi
serotonin_5ht1a,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,8.2,pKi
serotonin_5ht1a,agonists,tandospirone,O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)C2C1C1CCC2C1,Hs,Full agonist,8.2,pKi
serotonin_5ht1a,agonists,lurasidone,O=C1N(CC2CCCCC2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1C1CCC2C1,Rn,Partial agonist,8.2,pKi
serotonin_5ht1a,agonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Full agonist,8.0 – 8.3,pKi
serotonin_5ht1a,agonists,zalospirone,O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)C2C1C1C=CC2C2C1C=C2,Hs,Full agonist,8.1,pKi
serotonin_5ht1a,agonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Full agonist,8.0,pKi
serotonin_5ht1a,agonists,ocaperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C,Hs,Full agonist,8.0,pKi
serotonin_5ht1a,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,7.9,pKi
serotonin_5ht1a,agonists,buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,Hs,Partial agonist,7.7 – 8.0,pKi
serotonin_5ht1a,agonists,vortioxetine,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1,Hs,Partial agonist,7.8,pKi
serotonin_5ht1a,agonists,LY334370,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F,Hs,Full agonist,7.8,pKi
serotonin_5ht1a,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,7.7,pKi
serotonin_5ht1a,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,7.7,pKi
serotonin_5ht1a,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,7.6,pKi
serotonin_5ht1a,agonists,eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,7.4,pKi
serotonin_5ht1a,agonists,naratriptan,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C,Hs,Full agonist,7.1 – 7.6,pKi
serotonin_5ht1a,agonists,nafadotride,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2,Hs,Full agonist,7.3,pKi
serotonin_5ht1a,agonists,LP-44,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2,Hs,Agonist,7.3,pKi
serotonin_5ht1a,agonists,frovatriptan,CNC1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O,Hs,Agonist,7.2,pKi
serotonin_5ht1a,agonists,LP-12,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1,Hs,Agonist,7.2,pKi
serotonin_5ht1a,agonists,BMY-14802,Fc1ccc(cc1)C(CCCN1CCN(CC1)c1ncc(cn1)F)O,Hs,Full agonist,7.2,pKi
serotonin_5ht1a,agonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Full agonist,7.2,pKi
serotonin_5ht1a,agonists,avitriptan,COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)CS(=O)(=O)NC,Rn,Agonist,7.2,pKi
serotonin_5ht1a,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,7.1 – 7.2,pKi
serotonin_5ht1a,agonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Partial agonist,6.9,pKi
serotonin_5ht1a,agonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Full agonist,6.8 – 6.9,pKi
serotonin_5ht1a,agonists,EMDT,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC,Hs,Full agonist,6.8,pKi
serotonin_5ht1a,agonists,fluparoxan,Fc1cccc2c1OC1CNCC1O2,Hs,Partial agonist,6.8,pKi
serotonin_5ht1a,agonists,LP-211,N#Cc1ccc(cc1)CNC(=O)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1,Hs,Agonist,6.7,pKi
serotonin_5ht1a,agonists,zolmitriptan,CN(CCc1c[nH]c2c1cc(CC1COC(=O)N1)cc2)C,Hs,Full agonist,6.6,pKi
serotonin_5ht1a,agonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Full agonist,6.5 – 6.6,pKi
serotonin_5ht1a,agonists,piribedil,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2,Hs,Partial agonist,6.4,pKi
serotonin_5ht1a,agonists,rizatriptan,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C,Hs,Full agonist,6.4,pKi
serotonin_5ht1a,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,6.3,pKi
serotonin_5ht1a,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,6.3,pKi
serotonin_5ht1a,agonists,CP 93129,O=c1ccc2c([nH]1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,6.1,pKi
serotonin_5ht1a,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,6.0,pKi
serotonin_5ht1a,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,6.0,pKi
serotonin_5ht1a,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,5.8,pKi
serotonin_5ht1a,agonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Full agonist,5.6 – 5.8,pKi
serotonin_5ht1a,agonists,vilazodone,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,Hs,Partial agonist,9.5,pIC50
serotonin_5ht1a,agonists,BMY-7378,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2,Hs,Partial agonist,6.8 – 8.0,pIC50
serotonin_5ht1a,agonists,"L-772,405",OCC(c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1,Hs,Full agonist,7.2,pIC50
serotonin_5ht1a,agonists,ulotaront,CNCC1OCCc2c1scc2,Hs,Agonist,5.6,pIC50
serotonin_5ht1a,antagonists,[3H]robalzotan,NC(=O)c1ccc(c2c1CC(CO2)N(C1CCC1)C1CCC1)F,Hs,Antagonist,9.8,pKd
serotonin_5ht1a,antagonists,[3H]WAY100635,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1,Hs,Antagonist,9.5,pKd
serotonin_5ht1a,antagonists,[3H]p-MPPF,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)F)c1ccccn1,Hs,Antagonist,8.4,pKd
serotonin_5ht1a,antagonists,Rec 15/3079,COc1ccccc1N1CCN(CC1)CCN(c1ccccc1[N+](=O)[O-])C(=O)C1CCCCC1,Hs,Antagonist,9.7,pKi
serotonin_5ht1a,antagonists,NAN 190,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2,Hs,Antagonist,9.4,pKi
serotonin_5ht1a,antagonists,repinotan,O=C1c2ccccc2S(=O)(=O)N1CCCCNCC1CCc2c(O1)cccc2,Hs,Antagonist,9.4,pKi
serotonin_5ht1a,antagonists,robalzotan,NC(=O)c1ccc(c2c1CC(CO2)N(C1CCC1)C1CCC1)F,Hs,Antagonist,9.2,pKi
serotonin_5ht1a,antagonists,SB 649915,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C,Hs,Antagonist,8.6,pKi
serotonin_5ht1a,antagonists,WAY-100635,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1,Hs,Antagonist,7.9 – 9.2,pKi
serotonin_5ht1a,antagonists,p-MPPI,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)I)c1ccccn1,Hs,Antagonist,8.4,pKi
serotonin_5ht1a,antagonists,tiospirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2,Hs,Antagonist,8.3,pKi
serotonin_5ht1a,antagonists,(-)-tertatolol,OC(COc1cccc2c1SCCC2)CNC(C)(C)C,Hs,Antagonist,8.2,pKi
serotonin_5ht1a,antagonists,pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Hs,Antagonist,8.1,pKi
serotonin_5ht1a,antagonists,SB 272183,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1,Hs,Antagonist,8.0,pKi
serotonin_5ht1a,antagonists,WAY-100135,COc1ccccc1N1CCN(CC1)CC(C(=O)NC(C)(C)C)c1ccccc1,Hs,Antagonist,8.0,pKi
serotonin_5ht1a,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Antagonist,7.8 – 8.1,pKi
serotonin_5ht1a,antagonists,(S)-UH 301,CCCN(C1CCc2c(C1)c(O)ccc2F)CCC,Hs,Antagonist,7.9,pKi
serotonin_5ht1a,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,6.7 – 8.8,pKi
serotonin_5ht1a,antagonists,(-)-propranolol,OC(COc1cccc2c1cccc2)CNC(C)C,Hs,Antagonist,7.5,pKi
serotonin_5ht1a,antagonists,(S)-flurocarazolol,FCC(NCC(COc1cccc2c1c1ccccc1[nH]2)O)C,Hs,Antagonist,7.5,pKi
serotonin_5ht1a,antagonists,pizotifen,CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1,Hs,Antagonist,7.4,pKi
serotonin_5ht1a,antagonists,"GR 125,743",COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(c(c1)C)c1ccncc1,Hs,Antagonist,7.3,pKi
serotonin_5ht1a,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.3,pKi
serotonin_5ht1a,antagonists,fluspirilene,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,7.2,pKi
serotonin_5ht1a,antagonists,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,Hs,Antagonist,7.1,pKi
serotonin_5ht1a,antagonists,iloperidone,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C,Hs,Antagonist,7.0,pKi
serotonin_5ht1a,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,7.0,pKi
serotonin_5ht1a,antagonists,"GR 218,231",CCCN(C1CCc2c(C1)ccc(c2)CS(=O)(=O)c1ccc(cc1)OC)CCC,Hs,Antagonist,6.8,pKi
serotonin_5ht1a,antagonists,iloperidone,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C,Rn,Antagonist,6.8,pKi
serotonin_5ht1a,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,6.8,pKi
serotonin_5ht1a,antagonists,(R)-flurocarazolol,FCC(NCC(COc1cccc2c1c1ccccc1[nH]2)O)C,Hs,Antagonist,6.5,pKi
serotonin_5ht1a,antagonists,SB 714786,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2,Hs,Antagonist,6.5,pKi
serotonin_5ht1a,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,6.4 – 6.6,pKi
serotonin_5ht1a,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,6.5,pKi
serotonin_5ht1a,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,6.4 – 6.5,pKi
serotonin_5ht1a,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,6.4,pKi
serotonin_5ht1a,antagonists,cyamemazine,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1,Hs,Antagonist,6.3,pKi
serotonin_5ht1a,antagonists,9-OH-risperidone,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F,Hs,Antagonist,6.2,pKi
serotonin_5ht1a,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,6.2,pKi
serotonin_5ht1a,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Rn,Antagonist,6.2,pKi
serotonin_5ht1a,antagonists,MPDT,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1,Hs,Antagonist,5.8,pKi
serotonin_5ht1a,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,5.7 – 5.8,pKi
serotonin_5ht1a,antagonists,pipamperone,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N,Hs,Antagonist,5.6,pKi
serotonin_5ht1a,antagonists,raclopride,CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,Hs,Antagonist,5.2,pKi
serotonin_5ht1a,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,5.0,pKi
serotonin_5ht1a,antagonists,SDZ-216525,COC(=O)c1[nH]c2c(c1)c(ccc2)N1CCN(CC1)CCCCN1C(=O)c2c(S1(=O)=O)cccc2,Hs,Antagonist,7.8 – 8.2,pIC50
serotonin_5ht1a,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,5.2 – 5.5,pIC50
serotonin_5ht1a,antagonists,p-[18F]MPPF,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)F)c1ncccn1,Hs,Antagonist,-,-
serotonin_5ht1a,antagonists,[11C]WAY100635,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1,Hs,Antagonist,-,-
serotonin_5ht1a,allosterics,RS-30199,CN1CCc2c3C(C1)CCCc3ccc2Cl,Hs,Positive,7.1 – 7.5,pKi
serotonin_5ht1b,agonists,[3H]N-methyl-AZ10419369,CN1CCN(CC1)c1ccc(c2c1oc(cc2=O)C(=O)Nc1ccc(cc1)N1CCOCC1)C,Hs,Partial agonist,9.4,pKd
serotonin_5ht1b,agonists,[3H]8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,8.9,pKd
serotonin_5ht1b,agonists,[125I]GTI,NCCc1c[nH]c2c1cc(OCC(=O)NCC(=O)NC(C(=O)N)Cc1ccc(c(c1)I)O)cc2,Rn,Agonist,8.9,pKd
serotonin_5ht1b,agonists,[3H]alniditan,C(NCC1CCc2c(O1)cccc2)CCNC1=NCCCN1,Hs,Full agonist,8.6 – 9.0,pKd
serotonin_5ht1b,agonists,[3H]eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Partial agonist,8.5,pKd
serotonin_5ht1b,agonists,[3H]sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Partial agonist,8.0,pKd
serotonin_5ht1b,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,7.5 – 8.4,pKd
serotonin_5ht1b,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Rn,Partial agonist,9.7,pKi
serotonin_5ht1b,agonists,oxymetazoline,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C,Hs,Full agonist,9.5,pKi
serotonin_5ht1b,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,9.0 – 9.8,pKi
serotonin_5ht1b,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,9.4,pKi
serotonin_5ht1b,agonists,"L-694,247",NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C,Hs,Full agonist,9.2,pKi
serotonin_5ht1b,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,9.0,pKi
serotonin_5ht1b,agonists,alniditan,C(NCC1CCc2c(O1)cccc2)CCNC1=NCCCN1,Hs,Full agonist,8.8 – 9.0,pKi
serotonin_5ht1b,agonists,7-methoxy-1-naphthylpiperazine,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C,Hs,Full agonist,8.7,pKi
serotonin_5ht1b,agonists,CP94253,CCCOc1ccc2c(n1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,8.7,pKi
serotonin_5ht1b,agonists,dihydroergotamine,CN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,8.0 – 9.2,pKi
serotonin_5ht1b,agonists,CGS-12066,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F,Hs,Full agonist,8.1 – 8.7,pKi
serotonin_5ht1b,agonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Full agonist,8.3,pKi
serotonin_5ht1b,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,7.7 – 8.8,pKi
serotonin_5ht1b,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,7.4 – 9.0,pKi
serotonin_5ht1b,agonists,5-(nonyloxy)-tryptamine,CCCCCCCCCOc1ccc2c(c1)c(CCN)c[nH]2,Hs,Full agonist,8.2,pKi
serotonin_5ht1b,agonists,lysergol,OCC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3,Hs,Full agonist,7.5 – 8.9,pKi
serotonin_5ht1b,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Mm,Full agonist,8.1,pKi
serotonin_5ht1b,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Mm,Full agonist,8.1,pKi
serotonin_5ht1b,agonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Full agonist,8.1,pKi
serotonin_5ht1b,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,8.1,pKi
serotonin_5ht1b,agonists,naratriptan,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C,Hs,Partial agonist,8.1,pKi
serotonin_5ht1b,agonists,eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,8.0,pKi
serotonin_5ht1b,agonists,frovatriptan,CNC1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O,Hs,Agonist,8.0,pKi
serotonin_5ht1b,agonists,"BMS 181,101",COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(F)cc2,Hs,Partial agonist,7.6 – 8.1,pKi
serotonin_5ht1b,agonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Full agonist,7.7 – 7.9,pKi
serotonin_5ht1b,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,7.7,pKi
serotonin_5ht1b,agonists,zolmitriptan,CN(CCc1c[nH]c2c1cc(CC1COC(=O)N1)cc2)C,Hs,Partial agonist,7.7,pKi
serotonin_5ht1b,agonists,avitriptan,COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)CS(=O)(=O)NC,Hs,Agonist,7.7,pKi
serotonin_5ht1b,agonists,vortioxetine,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1,Hs,Partial agonist,7.5,pKi
serotonin_5ht1b,agonists,avitriptan,COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)CS(=O)(=O)NC,Rn,Agonist,7.4,pKi
serotonin_5ht1b,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,7.3 – 7.5,pKi
serotonin_5ht1b,agonists,dipropyl-5-CT,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,7.4,pKi
serotonin_5ht1b,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Partial agonist,6.5 – 8.1,pKi
serotonin_5ht1b,agonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Full agonist,7.3,pKi
serotonin_5ht1b,agonists,rizatriptan,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C,Hs,Partial agonist,6.9,pKi
serotonin_5ht1b,agonists,"L-775,606",Fc1cccc(c1)CCN1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1,Hs,Partial agonist,6.3 – 6.9,pKi
serotonin_5ht1b,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,6.6,pKi
serotonin_5ht1b,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,6.6,pKi
serotonin_5ht1b,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,6.2 – 6.9,pKi
serotonin_5ht1b,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,6.5,pKi
serotonin_5ht1b,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,6.3,pKi
serotonin_5ht1b,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,6.3,pKi
serotonin_5ht1b,agonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Full agonist,6.3,pKi
serotonin_5ht1b,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,6.3,pKi
serotonin_5ht1b,agonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Full agonist,6.2,pKi
serotonin_5ht1b,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,6.1,pKi
serotonin_5ht1b,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Full agonist,6.1,pKi
serotonin_5ht1b,agonists,2-methyl-5-HT,Cc1c(CCN)c2c([nH]1)ccc(c2)O,Hs,Full agonist,6.1,pKi
serotonin_5ht1b,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,5.8 – 6.0,pKi
serotonin_5ht1b,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,5.3,pKi
serotonin_5ht1b,agonists,almotriptan,CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C,Hs,Agonist,7.9,pIC50
serotonin_5ht1b,agonists,CP-122288,CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC1CCCN1C,Hs,Full agonist,7.6,pIC50
serotonin_5ht1b,agonists,"L-772,405",OCC(c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1,Hs,Full agonist,6.8,pIC50
serotonin_5ht1b,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,6.2,pIC50
serotonin_5ht1b,agonists,[11C]AZ10419369,CN1CCN(CC1)c1ccc(c2c1oc(cc2=O)C(=O)Nc1ccc(cc1)N1CCOCC1)C,Hs,Partial agonist,-,-
serotonin_5ht1b,antagonists,GR-55562,CN(CCCc1cc(ccc1O)C(=O)Nc1ccc(cc1)c1ccncc1)C,Hs,Antagonist,7.4,pKB
serotonin_5ht1b,antagonists,"[3H]GR 125,743",COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(c(c1)C)c1ccncc1,Hs,Antagonist,8.6 – 9.2,pKd
serotonin_5ht1b,antagonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,9.2,pKi
serotonin_5ht1b,antagonists,5-OH-DPAT,CCCN(C1CCc2c(C1)cccc2O)CCC,Mm,Antagonist,8.4,pKi
serotonin_5ht1b,antagonists,SB 224289,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Inverse agonist,8.2 – 8.6,pKi
serotonin_5ht1b,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Mm,Antagonist,8.3,pKi
serotonin_5ht1b,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Mm,Antagonist,8.3,pKi
serotonin_5ht1b,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Mm,Antagonist,8.3,pKi
serotonin_5ht1b,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Mm,Antagonist,8.3,pKi
serotonin_5ht1b,antagonists,SB236057,CCN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1nnc(o1)C,Hs,Inverse agonist,8.2,pKi
serotonin_5ht1b,antagonists,SB 272183,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1,Hs,Antagonist,8.1,pKi
serotonin_5ht1b,antagonists,(-)-pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Mm,Antagonist,8.1,pKi
serotonin_5ht1b,antagonists,cyanopindolol,N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2,Mm,Antagonist,8.1,pKi
serotonin_5ht1b,antagonists,SB 649915,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C,Hs,Antagonist,8.0,pKi
serotonin_5ht1b,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Inverse agonist,7.1 – 8.5,pKi
serotonin_5ht1b,antagonists,GR-55562,CN(CCCc1cc(ccc1O)C(=O)Nc1ccc(cc1)c1ccncc1)C,Hs,Antagonist,7.5,pKi
serotonin_5ht1b,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,6.8 – 7.6,pKi
serotonin_5ht1b,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.2,pKi
serotonin_5ht1b,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,7.2,pKi
serotonin_5ht1b,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,6.6 – 7.6,pKi
serotonin_5ht1b,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,7.0,pKi
serotonin_5ht1b,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,6.6 – 7.3,pKi
serotonin_5ht1b,antagonists,rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,6.5 – 7.4,pKi
serotonin_5ht1b,antagonists,9-OH-risperidone,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F,Hs,Antagonist,6.8,pKi
serotonin_5ht1b,antagonists,SB 714786,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2,Hs,Antagonist,6.7,pKi
serotonin_5ht1b,antagonists,(S)-flurocarazolol,FCC(NCC(COc1cccc2c1c1ccccc1[nH]2)O)C,Hs,Antagonist,6.5,pKi
serotonin_5ht1b,antagonists,pipamperone,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N,Hs,Antagonist,6.2,pKi
serotonin_5ht1b,antagonists,(R)-flurocarazolol,FCC(NCC(COc1cccc2c1c1ccccc1[nH]2)O)C,Hs,Antagonist,6.1,pKi
serotonin_5ht1b,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,6.1,pKi
serotonin_5ht1b,antagonists,(+)-WAY 100135,COc1ccccc1N1CCN(CC1)CC(C(=O)NC(C)(C)C)c1ccccc1,Hs,Antagonist,5.8,pKi
serotonin_5ht1b,antagonists,ocaperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C,Hs,Antagonist,6.9 – 7.2,pIC50
serotonin_5ht1b,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,6.0 – 6.5,pIC50
serotonin_5ht1b,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,5.2 – 5.4,pIC50
serotonin_5ht1b,allosterics,5-HT-moduline,,Hs,Negative,11.9,pIC50
serotonin_5ht1d,agonists,[3H]eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,9.1,pKd
serotonin_5ht1d,agonists,[3H]5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Agonist,9.1,pKd
serotonin_5ht1d,agonists,[3H]8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,9.0,pKd
serotonin_5ht1d,agonists,[125I]GTI,NCCc1c[nH]c2c1cc(OCC(=O)NCC(=O)NC(C(=O)N)Cc1ccc(c(c1)I)O)cc2,Rn,Agonist,8.9,pKd
serotonin_5ht1d,agonists,[3H]alniditan,C(NCC1CCc2c(O1)cccc2)CCNC1=NCCCN1,Hs,Full agonist,8.9 – 8.9,pKd
serotonin_5ht1d,agonists,[3H]5-HT,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.2 – 8.6,pKd
serotonin_5ht1d,agonists,[3H]sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,8.2,pKd
serotonin_5ht1d,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Rn,Full agonist,9.6,pKi
serotonin_5ht1d,agonists,dihydroergotamine,CN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,9.2 – 9.9,pKi
serotonin_5ht1d,agonists,oxymetazoline,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C,Hs,Partial agonist,9.4,pKi
serotonin_5ht1d,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,9.3,pKi
serotonin_5ht1d,agonists,7-methoxy-1-naphthylpiperazine,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C,Hs,Full agonist,9.2,pKi
serotonin_5ht1d,agonists,lysergol,OCC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3,Hs,Full agonist,9.2,pKi
serotonin_5ht1d,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Agonist,9.1,pKi
serotonin_5ht1d,agonists,PNU109291,CNC(=O)c1ccc2c(c1)CCOC2CCN1CCN(CC1)c1ccc(cc1)OC,Gg,Agonist,9.1,pKi
serotonin_5ht1d,agonists,alniditan,C(NCC1CCc2c(O1)cccc2)CCNC1=NCCCN1,Hs,Full agonist,8.7 – 9.4,pKi
serotonin_5ht1d,agonists,"L-694,247",NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C,Hs,Agonist,9.0,pKi
serotonin_5ht1d,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,9.0,pKi
serotonin_5ht1d,agonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Full agonist,9.0,pKi
serotonin_5ht1d,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,8.6 – 9.2,pKi
serotonin_5ht1d,agonists,eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,8.9,pKi
serotonin_5ht1d,agonists,zolmitriptan,CN(CCc1c[nH]c2c1cc(CC1COC(=O)N1)cc2)C,Hs,Full agonist,8.9,pKi
serotonin_5ht1d,agonists,lysergic acid,CN1CC(C=C2C1Cc1c[nH]c3c1c2ccc3)C(=O)O,Hs,Full agonist,8.8 – 9.0,pKi
serotonin_5ht1d,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,8.6 – 9.1,pKi
serotonin_5ht1d,agonists,naratriptan,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C,Hs,Full agonist,8.4 – 9.0,pKi
serotonin_5ht1d,agonists,CGS-12066,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F,Hs,Full agonist,8.5 – 8.6,pKi
serotonin_5ht1d,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.0 – 9.0,pKi
serotonin_5ht1d,agonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Full agonist,8.4,pKi
serotonin_5ht1d,agonists,frovatriptan,CNC1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O,Hs,Agonist,8.4,pKi
serotonin_5ht1d,agonists,avitriptan,COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)CS(=O)(=O)NC,Hs,Agonist,8.4,pKi
serotonin_5ht1d,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,8.0 – 8.7,pKi
serotonin_5ht1d,agonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Full agonist,8.2,pKi
serotonin_5ht1d,agonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Full agonist,8.1 – 8.2,pKi
serotonin_5ht1d,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Partial agonist,8.1,pKi
serotonin_5ht1d,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,7.4 – 8.7,pKi
serotonin_5ht1d,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,8.0,pKi
serotonin_5ht1d,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,7.9,pKi
serotonin_5ht1d,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Partial agonist,7.9,pKi
serotonin_5ht1d,agonists,rizatriptan,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C,Hs,Full agonist,7.9,pKi
serotonin_5ht1d,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,7.8,pKi
serotonin_5ht1d,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,7.7,pKi
serotonin_5ht1d,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,7.6,pKi
serotonin_5ht1d,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Full agonist,7.2,pKi
serotonin_5ht1d,agonists,dimethyltryptamine,CN(CCc1c[nH]c2c1cccc2)C,Hs,Full agonist,7.0 – 7.3,pKi
serotonin_5ht1d,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,7.1 – 7.2,pKi
serotonin_5ht1d,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,6.9 – 7.3,pKi
serotonin_5ht1d,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,6.8 – 7.4,pKi
serotonin_5ht1d,agonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Partial agonist,7.0 – 7.2,pKi
serotonin_5ht1d,agonists,EMDT,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC,Hs,Full agonist,6.5,pKi
serotonin_5ht1d,agonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Full agonist,6.4,pKi
serotonin_5ht1d,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,6.1 – 6.6,pKi
serotonin_5ht1d,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,6.2,pKi
serotonin_5ht1d,agonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Full agonist,6.2,pKi
serotonin_5ht1d,agonists,2-methyl-5-HT,Cc1c(CCN)c2c([nH]1)ccc(c2)O,Hs,Full agonist,5.7 – 6.2,pKi
serotonin_5ht1d,agonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Full agonist,5.7,pKi
serotonin_5ht1d,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,5.1,pKi
serotonin_5ht1d,agonists,dipropyl-5-CT,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,7.9,pIC50
serotonin_5ht1d,agonists,almotriptan,CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C,Hs,Agonist,7.9,pIC50
serotonin_5ht1d,agonists,CP-122288,CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC1CCCN1C,Hs,Full agonist,7.7,pIC50
serotonin_5ht1d,antagonists,"[3H]GR 125,743",COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(c(c1)C)c1ccncc1,Hs,Antagonist,8.6,pKd
serotonin_5ht1d,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,9.3,pKi
serotonin_5ht1d,antagonists,SB 714786,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2,Hs,Antagonist,9.1,pKi
serotonin_5ht1d,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,8.6 – 9.2,pKi
serotonin_5ht1d,antagonists,SB 649915,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C,Hs,Antagonist,8.8,pKi
serotonin_5ht1d,antagonists,ocaperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C,Hs,Antagonist,8.7 – 8.8,pKi
serotonin_5ht1d,antagonists,SB 272183,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1,Hs,Antagonist,8.7,pKi
serotonin_5ht1d,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,8.4 – 8.9,pKi
serotonin_5ht1d,antagonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,8.3 – 8.6,pKi
serotonin_5ht1d,antagonists,9-OH-risperidone,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F,Hs,Antagonist,7.9,pKi
serotonin_5ht1d,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,7.8 – 8.0,pKi
serotonin_5ht1d,antagonists,bufotenine,CN(CCc1c[nH]c2c1cc(O)cc2)C,Hs,Antagonist,7.7 – 8.0,pKi
serotonin_5ht1d,antagonists,rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.8,pKi
serotonin_5ht1d,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Inverse agonist,7.3 – 8.2,pKi
serotonin_5ht1d,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,7.6,pKi
serotonin_5ht1d,antagonists,(+)-WAY 100135,COc1ccccc1N1CCN(CC1)CC(C(=O)NC(C)(C)C)c1ccccc1,Hs,Antagonist,7.6,pKi
serotonin_5ht1d,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,7.4 – 7.5,pKi
serotonin_5ht1d,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.2 – 7.7,pKi
serotonin_5ht1d,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,7.2,pKi
serotonin_5ht1d,antagonists,cyanopindolol,N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2,Hs,Antagonist,7.1,pKi
serotonin_5ht1d,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,6.9,pKi
serotonin_5ht1d,antagonists,pipamperone,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N,Hs,Antagonist,6.8,pKi
serotonin_5ht1d,antagonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Hs,Antagonist,6.7,pKi
serotonin_5ht1d,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,6.6,pKi
serotonin_5ht1d,antagonists,LY310762,CC1(C)C2=C(C=CC=C2)N(CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F)C1=O,Cp,Antagonist,6.6,pKi
serotonin_5ht1d,antagonists,SB 224289,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,6.3,pKi
serotonin_5ht1d,antagonists,fluspirilene,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,6.0,pKi
serotonin_5ht1d,antagonists,SB 277011-A,N#Cc1ccc2c(c1)CCN(C2)CCC1CCC(CC1)NC(=O)c1ccnc2c1cccc2,Hs,Antagonist,5.8,pKi
serotonin_5ht1d,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.5 – 6.0,pKi
serotonin_5ht1d,antagonists,MPDT,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1,Hs,Antagonist,5.2,pKi
serotonin_5ht1d,antagonists,"L-772,405",OCC(c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1,Hs,Antagonist,9.0,pIC50
serotonin_5ht1d,antagonists,vortioxetine,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1,Rn,Antagonist,5.4,pIC50
serotonin_5ht1d,allosterics,5-HT-moduline,,Hs,Negative,12.0,pIC50
serotonin_5ht1e,agonists,[3H]5-HT,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.1 – 8.2,pKd
serotonin_5ht1e,agonists,BRL-54443,CN1CCC(CC1)c1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.7,pKi
serotonin_5ht1e,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.0 – 8.2,pKi
serotonin_5ht1e,agonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Full agonist,8.0,pKi
serotonin_5ht1e,agonists,naratriptan,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C,Hs,Full agonist,7.7,pKi
serotonin_5ht1e,agonists,zolmitriptan,CN(CCc1c[nH]c2c1cc(CC1COC(=O)N1)cc2)C,Hs,Full agonist,7.7,pKi
serotonin_5ht1e,agonists,lysergol,OCC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3,Hs,Full agonist,7.4,pKi
serotonin_5ht1e,agonists,ergometrine,OCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)C,Hs,Full agonist,7.3,pKi
serotonin_5ht1e,agonists,eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,7.2,pKi
serotonin_5ht1e,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,6.9 – 7.0,pKi
serotonin_5ht1e,agonists,rizatriptan,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C,Hs,Full agonist,6.8,pKi
serotonin_5ht1e,agonists,5-BODMT,CCCC(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Agonist,6.6,pKi
serotonin_5ht1e,agonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Full agonist,6.4,pKi
serotonin_5ht1e,agonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Full agonist,6.4,pKi
serotonin_5ht1e,agonists,EMDT,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC,Hs,Full agonist,6.3,pKi
serotonin_5ht1e,agonists,5-fluorotryptamine,NCCc1c[nH]c2c1cc(F)cc2,Hs,Full agonist,6.3,pKi
serotonin_5ht1e,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,6.2 – 6.3,pKi
serotonin_5ht1e,agonists,5-MeO-DMT,COc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,6.1 – 6.3,pKi
serotonin_5ht1e,agonists,2-methyl-5-HT,Cc1c(CCN)c2c([nH]1)ccc(c2)O,Hs,Full agonist,6.1,pKi
serotonin_5ht1e,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,5.6 – 6.5,pKi
serotonin_5ht1e,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,5.9,pKi
serotonin_5ht1e,agonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Full agonist,5.9,pKi
serotonin_5ht1e,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,5.5 – 6.2,pKi
serotonin_5ht1e,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,5.8,pKi
serotonin_5ht1e,agonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Full agonist,5.7,pKi
serotonin_5ht1e,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,5.6 – 5.8,pKi
serotonin_5ht1e,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,5.5 – 5.8,pKi
serotonin_5ht1e,agonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Full agonist,5.6,pKi
serotonin_5ht1e,agonists,dihydroergotamine,CN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,5.6,pKi
serotonin_5ht1e,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.5,pKi
serotonin_5ht1e,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,5.4,pKi
serotonin_5ht1e,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Hs,Partial agonist,5.4,pKi
serotonin_5ht1e,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,5.1 – 5.5,pKi
serotonin_5ht1e,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,5.2 – 5.4,pKi
serotonin_5ht1e,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,5.2,pKi
serotonin_5ht1e,antagonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Hs,Antagonist,7.0 – 7.2,pKi
serotonin_5ht1e,antagonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Antagonist,6.7 – 7.0,pKi
serotonin_5ht1e,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Antagonist,6.7 – 7.0,pKi
serotonin_5ht1e,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,6.5 – 6.8,pKi
serotonin_5ht1e,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,6.5,pKi
serotonin_5ht1e,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,6.4,pKi
serotonin_5ht1e,antagonists,9-OH-risperidone,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F,Hs,Antagonist,6.0,pKi
serotonin_5ht1e,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,5.9,pKi
serotonin_5ht1e,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,5.9,pKi
serotonin_5ht1e,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,5.6 – 6.1,pKi
serotonin_5ht1e,antagonists,fluspirilene,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.6,pKi
serotonin_5ht1e,antagonists,rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,5.4 – 5.5,pKi
serotonin_5ht1f,agonists,[3H]LY334370,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F,Hs,Full agonist,9.4,pKd
serotonin_5ht1f,agonists,[125I]LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)I)CC,Mm,Agonist,9.0,pKd
serotonin_5ht1f,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.0,pKd
serotonin_5ht1f,agonists,BRL-54443,CN1CCC(CC1)c1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.9,pKi
serotonin_5ht1f,agonists,LY334370,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F,Hs,Full agonist,8.7,pKi
serotonin_5ht1f,agonists,lasmiditan,CN1CCC(CC1)C(=O)c1cccc(n1)NC(=O)c1c(F)cc(cc1F)F,Hs,Full agonist,8.7,pKi
serotonin_5ht1f,agonists,5-BODMT,CCCC(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Agonist,8.4,pKi
serotonin_5ht1f,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,8.2,pKi
serotonin_5ht1f,agonists,naratriptan,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C,Hs,Full agonist,8.2,pKi
serotonin_5ht1f,agonists,eletriptan,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,Hs,Full agonist,8.0,pKi
serotonin_5ht1f,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,7.7 – 8.0,pKi
serotonin_5ht1f,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,7.2 – 7.9,pKi
serotonin_5ht1f,agonists,zolmitriptan,CN(CCc1c[nH]c2c1cc(CC1COC(=O)N1)cc2)C,Hs,Full agonist,7.4 – 7.5,pKi
serotonin_5ht1f,agonists,5-MeO-DMT,COc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,7.4,pKi
serotonin_5ht1f,agonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Full agonist,6.9,pKi
serotonin_5ht1f,agonists,dihydroergotamine,CN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,6.6 – 7.1,pKi
serotonin_5ht1f,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,6.4 – 7.2,pKi
serotonin_5ht1f,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Full agonist,6.8,pKi
serotonin_5ht1f,agonists,NAN 190,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2,Hs,Partial agonist,6.7,pKi
serotonin_5ht1f,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,6.7,pKi
serotonin_5ht1f,agonists,rizatriptan,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C,Hs,Full agonist,6.4 – 6.8,pKi
serotonin_5ht1f,agonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Full agonist,6.5,pKi
serotonin_5ht1f,agonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Full agonist,6.5,pKi
serotonin_5ht1f,agonists,2-methyl-5-HT,Cc1c(CCN)c2c([nH]1)ccc(c2)O,Hs,Full agonist,6.4,pKi
serotonin_5ht1f,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,6.1,pKi
serotonin_5ht1f,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,6.0,pKi
serotonin_5ht1f,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,6.0,pKi
serotonin_5ht1f,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,5.9,pKi
serotonin_5ht1f,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.8,pKi
serotonin_5ht1f,agonists,dipropyl-5-CT,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,5.8,pKi
serotonin_5ht1f,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,5.8,pKi
serotonin_5ht1f,agonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Full agonist,5.6,pKi
serotonin_5ht1f,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,5.6,pKi
serotonin_5ht1f,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,5.5,pKi
serotonin_5ht1f,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Rn,Full agonist,7.3,pIC50
serotonin_5ht1f,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Rn,Full agonist,7.2,pIC50
serotonin_5ht1f,agonists,sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,7.2,pIC50
serotonin_5ht1f,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Rn,Full agonist,5.6,pIC50
serotonin_5ht1f,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,8.2,pKi
serotonin_5ht1f,antagonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Hs,Antagonist,7.5,pKi
serotonin_5ht1f,antagonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Antagonist,7.3,pKi
serotonin_5ht1f,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.0,pKi
serotonin_5ht1f,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,6.5,pKi
serotonin_5ht1f,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,6.4,pKi
serotonin_5ht1f,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Antagonist,6.2,pKi
serotonin_5ht1f,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Antagonist,5.9,pKi
serotonin_5ht1f,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Antagonist,7.8,pIC50
serotonin_5ht1f,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Rn,Antagonist,6.3,pIC50
serotonin_5ht1f,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Rn,Antagonist,6.2,pIC50
serotonin_5ht2a,agonists,[3H](+)DOB,COc1cc(Br)c(cc1CC(N)C)OC,Hs,Full agonist,9.1,pKd
serotonin_5ht2a,agonists,[125I]DOI,COc1cc(I)c(cc1CC(N)C)OC,Rn,Full agonist,9.1,pKd
serotonin_5ht2a,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,8.9,pKd
serotonin_5ht2a,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,9.4,pKi
serotonin_5ht2a,agonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Hs,Full agonist,9.4,pKi
serotonin_5ht2a,agonists,(R)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,9.2 – 9.3,pKi
serotonin_5ht2a,agonists,2C-B,COC1=C(CCN)C=C(C(=C1)Br)OC,Hs,Agonist,9.2,pKi
serotonin_5ht2a,agonists,(+)-LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,9.1,pKi
serotonin_5ht2a,agonists,brolamfetamine,COc1cc(Br)c(cc1CC(N)C)OC,Hs,Full agonist,8.9 – 9.2,pKi
serotonin_5ht2a,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Partial agonist,9.0,pKi
serotonin_5ht2a,agonists,(+)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,9.0,pKi
serotonin_5ht2a,agonists,S 16924,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2,Hs,Full agonist,9.0,pKi
serotonin_5ht2a,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,8.9,pKi
serotonin_5ht2a,agonists,AL-37350A,CC(Cc1c[nH]c2c1c1CCCOc1cc2)N,Hs,Full agonist,8.7,pKi
serotonin_5ht2a,agonists,NBOMe,COC1=C(C=CC=C1)CNCCC2=C(C=C(C(=C2)OC)I)OC,Rn,Agonist,8.7,pKi
serotonin_5ht2a,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,8.6,pKi
serotonin_5ht2a,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Rn,Full agonist,8.5,pKi
serotonin_5ht2a,agonists,ergometrine,OCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)C,Rn,Full agonist,8.5,pKi
serotonin_5ht2a,agonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,8.3,pKi
serotonin_5ht2a,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.4 – 9.2,pKi
serotonin_5ht2a,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,8.2,pKi
serotonin_5ht2a,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,8.1,pKi
serotonin_5ht2a,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Rn,Full agonist,8.1,pKi
serotonin_5ht2a,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Rn,Partial agonist,8.0,pKi
serotonin_5ht2a,agonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Rn,Full agonist,7.9,pKi
serotonin_5ht2a,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Full agonist,7.8,pKi
serotonin_5ht2a,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,7.5 – 8.1,pKi
serotonin_5ht2a,agonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Partial agonist,7.8,pKi
serotonin_5ht2a,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,7.8,pKi
serotonin_5ht2a,agonists,brolamfetamine,COc1cc(Br)c(cc1CC(N)C)OC,Rn,Full agonist,7.8,pKi
serotonin_5ht2a,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Rn,Partial agonist,7.7,pKi
serotonin_5ht2a,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,7.5,pKi
serotonin_5ht2a,agonists,Org 12962,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F,Hs,Full agonist,7.5,pKi
serotonin_5ht2a,agonists,ORG-37684,COc1ccc2c(c1OC1CNCC1)CCC2,Hs,Full agonist,7.5,pKi
serotonin_5ht2a,agonists,N-1-isopropyl-5-MeOT,NCCc1cn(c2c1cc(OC)cc2)C(C)C,Rn,Full agonist,7.4,pKi
serotonin_5ht2a,agonists,Ro 60-0175,CC(Cn1ccc2c1cc(Cl)c(c2)F)N,Hs,Full agonist,7.4,pKi
serotonin_5ht2a,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Full agonist,7.3,pKi
serotonin_5ht2a,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,6.0 – 8.4,pKi
serotonin_5ht2a,agonists,BW723C86,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N,Hs,Full agonist,7.2,pKi
serotonin_5ht2a,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Hs,Partial agonist,6.8 – 7.5,pKi
serotonin_5ht2a,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Rn,Full agonist,7.1,pKi
serotonin_5ht2a,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Rn,Full agonist,7.1,pKi
serotonin_5ht2a,agonists,N-1-isopropyltryptamine,NCCc1cn(c2c1cccc2)C(C)C,Rn,Full agonist,7.1,pKi
serotonin_5ht2a,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,7.0,pKi
serotonin_5ht2a,agonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Full agonist,7.0,pKi
serotonin_5ht2a,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,6.9,pKi
serotonin_5ht2a,agonists,quipazine,N1CCN(CC1)c1ccc2c(n1)cccc2,Hs,Full agonist,6.9,pKi
serotonin_5ht2a,agonists,DOM,COc1cc(C)c(cc1CC(N)C)OC,Rn,Full agonist,6.8,pKi
serotonin_5ht2a,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,6.8,pKi
serotonin_5ht2a,agonists,donitriptan,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2,Hs,Full agonist,6.7,pKi
serotonin_5ht2a,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Full agonist,6.6,pKi
serotonin_5ht2a,agonists,N-1-isopropyltryptamine,NCCc1cn(c2c1cccc2)C(C)C,Hs,Full agonist,6.6,pKi
serotonin_5ht2a,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,5.5 – 7.6,pKi
serotonin_5ht2a,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,6.5,pKi
serotonin_5ht2a,agonists,LP-44,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2,Hs,Agonist,6.5,pKi
serotonin_5ht2a,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Rn,Partial agonist,6.4,pKi
serotonin_5ht2a,agonists,VER-3323,CC(CN1CCc2c1cc(Br)cc2)N,Hs,Full agonist,6.4,pKi
serotonin_5ht2a,agonists,N-1-isopropyl-5-MeOT,NCCc1cn(c2c1cc(OC)cc2)C(C)C,Hs,Full agonist,6.3,pKi
serotonin_5ht2a,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Rn,Full agonist,6.0 – 6.5,pKi
serotonin_5ht2a,agonists,relenopride,COc1cc(N)c(cc1C(=O)NCC1CCN(CC1)CCC(c1ccc(cc1)F)OC(=O)N)Cl,Hs,Agonist,6.2,pKi
serotonin_5ht2a,agonists,MK-212,Clc1cncc(n1)N1CCNCC1,Hs,Full agonist,6.0,pKi
serotonin_5ht2a,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,5.9,pKi
serotonin_5ht2a,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Rn,Full agonist,5.9,pKi
serotonin_5ht2a,agonists,LP-12,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1,Hs,Agonist,5.8,pKi
serotonin_5ht2a,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.6,pKi
serotonin_5ht2a,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,5.4,pKi
serotonin_5ht2a,agonists,CGS-12066,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F,Hs,Full agonist,5.4,pKi
serotonin_5ht2a,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,5.0 – 5.5,pKi
serotonin_5ht2a,agonists,pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Hs,Full agonist,5.0,pKi
serotonin_5ht2a,agonists,psilocin,CN(CCc1c[nH]c2c1c(O)ccc2)C,Hs,Agonist,7.6,pEC50
serotonin_5ht2a,agonists,(R)-70 [PMID: 36171289],C[C@@H]1C=C(CN(C)C1)C2=CNC3=C2C=CC=N3,Hs,Partial agonist,7.0,pEC50
serotonin_5ht2a,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,6.8,pEC50
serotonin_5ht2a,agonists,mescaline,COC1=CC(=CC(=C1OC)OC)CCN,Hs,Agonist,5.6,pEC50
serotonin_5ht2a,antagonists,[3H]fananserin,Fc1ccc(cc1)N1CCN(CC1)CCCN1c2cccc3c2c(S1(=O)=O)ccc3,Rn,Antagonist,9.9,pKd
serotonin_5ht2a,antagonists,[3H]ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,8.6 – 9.7,pKd
serotonin_5ht2a,antagonists,[3H]N-methylspiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1,Rn,Antagonist,9.1,pKd
serotonin_5ht2a,antagonists,[3H]ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Rn,Antagonist,8.8,pKd
serotonin_5ht2a,antagonists,compound 3b [PMID:28943244],COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1,Hs,Antagonist,10.6,pKi
serotonin_5ht2a,antagonists,asenapine,Clc1ccc2c(c1)C1CN(CC1c1c(O2)cccc1)C,Hs,Antagonist,10.2,pKi
serotonin_5ht2a,antagonists,MT-1207,C1=CC2=C(C=C1)SN=C2N3CCN(CCCCN4C5=C(C=CC=C5)N=N4)CC3,Hs,Antagonist,10.1,pKi
serotonin_5ht2a,antagonists,AC-90179,COc1ccc(cc1)CC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)C,Hs,Inverse agonist,9.7,pKi
serotonin_5ht2a,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Inverse agonist,9.3 – 10.0,pKi
serotonin_5ht2a,antagonists,pimavanserin,CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C,Hs,Inverse agonist,9.3,pKi
serotonin_5ht2a,antagonists,lumateperone,Fc1ccc(cc1)C(=O)CCCN1CCC2C(C1)c1cccc3c1N2CCN3C,Hs,Antagonist,9.3,pKi
serotonin_5ht2a,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Antagonist,9.2 – 9.4,pKi
serotonin_5ht2a,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Rn,Antagonist,9.2,pKi
serotonin_5ht2a,antagonists,LY86057,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O,Hs,Antagonist,9.2,pKi
serotonin_5ht2a,antagonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Antagonist,8.8 – 9.5,pKi
serotonin_5ht2a,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Rn,Antagonist,9.0 – 9.2,pKi
serotonin_5ht2a,antagonists,[11C]GSK215083,CN1CCN(CC1)c1cccc2c1ncc(c2)S(=O)(=O)c1cccc(c1)F,Hs,Antagonist,9.1,pKi
serotonin_5ht2a,antagonists,blonanserin,CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F,Hs,Antagonist,9.1,pKi
serotonin_5ht2a,antagonists,9-OH-risperidone,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F,Hs,Antagonist,9.0,pKi
serotonin_5ht2a,antagonists,amoxapine,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1,Rn,Antagonist,9.0,pKi
serotonin_5ht2a,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Antagonist,8.4 – 9.5,pKi
serotonin_5ht2a,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Rn,Inverse agonist,8.9,pKi
serotonin_5ht2a,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,8.1 – 9.7,pKi
serotonin_5ht2a,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,8.3 – 9.4,pKi
serotonin_5ht2a,antagonists,cyamemazine,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1,Hs,Antagonist,8.8,pKi
serotonin_5ht2a,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Rn,Antagonist,8.6 – 9.0,pKi
serotonin_5ht2a,antagonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Antagonist,8.6 – 8.9,pKi
serotonin_5ht2a,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Rn,Inverse agonist,8.7,pKi
serotonin_5ht2a,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Rn,Antagonist,8.4 – 9.0,pKi
serotonin_5ht2a,antagonists,lurasidone,O=C1N(CC2CCCCC2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1C1CCC2C1,Rn,Antagonist,8.7,pKi
serotonin_5ht2a,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Hs,Antagonist,7.7 – 9.6,pKi
serotonin_5ht2a,antagonists,(+)-butaclamol,OC1(CCN2C(C1)c1cccc3c1C(C2)c1ccccc1CC3)C(C)(C)C,Hs,Antagonist,8.6,pKi
serotonin_5ht2a,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,7.8 – 9.4,pKi
serotonin_5ht2a,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,8.6,pKi
serotonin_5ht2a,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,8.6,pKi
serotonin_5ht2a,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Rn,Antagonist,8.6,pKi
serotonin_5ht2a,antagonists,BF-1,CCOc1ccc2c(c1)Sc1c(C2=C2CCN(CC2)C)c(OC)ccc1,Hs,Antagonist,8.6,pKi
serotonin_5ht2a,antagonists,EGIS-11150,Fc1ccc2c(c1)onc2C1CCN(CC1)CCNc1cnn(c(=O)c1Cl)C,Hs,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Rn,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,LY215840,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C(C)C)C(=O)NC1CCCC1O,Rn,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,LY53857,CC(C(O)C)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Rn,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,amesergide,O=C(C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1,Rn,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,sarpogrelate,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C,Hs,Antagonist,8.5,pKi
serotonin_5ht2a,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,8.4,pKi
serotonin_5ht2a,antagonists,LY108742,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C)C)O,Rn,Antagonist,8.4,pKi
serotonin_5ht2a,antagonists,sergolexole,COC1CCC(CC1)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Rn,Antagonist,8.4,pKi
serotonin_5ht2a,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Inverse agonist,7.6 – 9.0,pKi
serotonin_5ht2a,antagonists,pipamperone,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N,Hs,Antagonist,8.3,pKi
serotonin_5ht2a,antagonists,nefazodone,CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl,Hs,Antagonist,8.2,pKi
serotonin_5ht2a,antagonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Antagonist,8.2,pKi
serotonin_5ht2a,antagonists,perphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,8.2,pKi
serotonin_5ht2a,antagonists,amitriptyline,CN(CCC=C1c2ccccc2CCc2c1cccc2)C,Rn,Antagonist,8.0 – 8.4,pKi
serotonin_5ht2a,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Inverse agonist,8.1,pKi
serotonin_5ht2a,antagonists,loxapine,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2,Hs,Inverse agonist,8.1,pKi
serotonin_5ht2a,antagonists,fluspirilene,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,8.0,pKi
serotonin_5ht2a,antagonists,amesergide,O=C(C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1,Hs,Antagonist,8.0,pKi
serotonin_5ht2a,antagonists,trazodone,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,Rn,Antagonist,7.7 – 8.2,pKi
serotonin_5ht2a,antagonists,LY215840,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C(C)C)C(=O)NC1CCCC1O,Hs,Antagonist,7.9,pKi
serotonin_5ht2a,antagonists,trifluoperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.9,pKi
serotonin_5ht2a,antagonists,LY86057,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O,Rn,Antagonist,7.8,pKi
serotonin_5ht2a,antagonists,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,Hs,Antagonist,7.4 – 8.0,pKi
serotonin_5ht2a,antagonists,sergolexole,COC1CCC(CC1)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Hs,Antagonist,7.7,pKi
serotonin_5ht2a,antagonists,spiramide,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,7.6,pKi
serotonin_5ht2a,antagonists,LY53857,CC(C(O)C)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Hs,Antagonist,7.6,pKi
serotonin_5ht2a,antagonists,glemanserin,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1,Hs,Antagonist,7.6,pKi
serotonin_5ht2a,antagonists,fluphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,7.5,pKi
serotonin_5ht2a,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Rn,Antagonist,7.4,pKi
serotonin_5ht2a,antagonists,trazodone,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,Hs,Antagonist,7.4,pKi
serotonin_5ht2a,antagonists,pimozide,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2,Hs,Antagonist,7.1 – 7.7,pKi
serotonin_5ht2a,antagonists,flibanserin,O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2,Hs,Antagonist,7.3,pKi
serotonin_5ht2a,antagonists,thiothixene,CN1CCN(CC1)CCC=C1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C,Hs,Antagonist,7.3,pKi
serotonin_5ht2a,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,7.3,pKi
serotonin_5ht2a,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Hs,Antagonist,7.0 – 7.5,pKi
serotonin_5ht2a,antagonists,LY314228,CCCc1c(COc2ccc(cc2)C=NN=C(N)N)ccc(c1O)C(=O)C,Hs,Antagonist,7.2,pKi
serotonin_5ht2a,antagonists,mirtazapine,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1,Hs,Antagonist,7.2,pKi
serotonin_5ht2a,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,6.7 – 7.3,pKi
serotonin_5ht2a,antagonists,LY320954,CCCc1c(COc2ccc(cc2)C=NN=C(N)N)ccc(c1O)C(=O)CC,Hs,Antagonist,7.0,pKi
serotonin_5ht2a,antagonists,SB 228357,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1,Hs,Antagonist,6.9 – 7.0,pKi
serotonin_5ht2a,antagonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Antagonist,6.9,pKi
serotonin_5ht2a,antagonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Antagonist,6.9,pKi
serotonin_5ht2a,antagonists,LY063518,NC(=N)NN=C(c1ccc(s1)Cl)c1ccccc1,Hs,Antagonist,6.9,pKi
serotonin_5ht2a,antagonists,bufotenine,CN(CCc1c[nH]c2c1cc(O)cc2)C,Hs,Antagonist,6.8,pKi
serotonin_5ht2a,antagonists,RS-102221,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F,Rn,Antagonist,6.8,pKi
serotonin_5ht2a,antagonists,SB 215505,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2,Hs,Antagonist,6.8,pKi
serotonin_5ht2a,antagonists,SB 243213,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,6.8,pKi
serotonin_5ht2a,antagonists,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,Hs,Antagonist,6.4 – 7.0,pKi
serotonin_5ht2a,antagonists,EGIS-7625,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-],Rn,Antagonist,6.5,pKi
serotonin_5ht2a,antagonists,"L-741,626",Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,Hs,Antagonist,6.5,pKi
serotonin_5ht2a,antagonists,fluoxetine,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Rn,Antagonist,6.5,pKi
serotonin_5ht2a,antagonists,molindone,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,Hs,Antagonist,6.5,pKi
serotonin_5ht2a,antagonists,SB 242084,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,6.1 – 6.8,pKi
serotonin_5ht2a,antagonists,MPDT,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1,Rn,Antagonist,6.3,pKi
serotonin_5ht2a,antagonists,SB 221284,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1,Hs,Antagonist,6.3,pKi
serotonin_5ht2a,antagonists,SDZ SER-082,CN1CCC2C(C1)c1cccc3c1N(C2)CC3,Hs,Antagonist,6.3,pKi
serotonin_5ht2a,antagonists,duloxetine,CNCCC(c1cccs1)Oc1cccc2c1cccc2,Hs,Antagonist,6.3,pKi
serotonin_5ht2a,antagonists,EGIS-7625,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-],Hs,Antagonist,6.2,pKi
serotonin_5ht2a,antagonists,norfluoxetine,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Rn,Antagonist,6.2,pKi
serotonin_5ht2a,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,6.0,pKi
serotonin_5ht2a,antagonists,RS-127445,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C,Hs,Antagonist,6.0,pKi
serotonin_5ht2a,antagonists,RS-102221,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F,Hs,Antagonist,5.5 – 6.0,pKi
serotonin_5ht2a,antagonists,SB 206553,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1,Hs,Antagonist,5.6 – 5.8,pKi
serotonin_5ht2a,antagonists,agomelatine,COc1ccc2c(c1)c(CCNC(=O)C)ccc2,Hs,Antagonist,5.4,pKi
serotonin_5ht2a,antagonists,SB 224289,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,5.3,pKi
serotonin_5ht2a,antagonists,pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Hs,Antagonist,5.0,pKi
serotonin_5ht2a,antagonists,perospirone,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)C2C1CCCC2,Rn,Antagonist,4.7,pKi
serotonin_5ht2a,antagonists,MT-1207,C1=CC2=C(C=C1)SN=C2N3CCN(CCCCN4C5=C(C=CC=C5)N=N4)CC3,Hs,Antagonist,9.5,pIC50
serotonin_5ht2a,antagonists,volinanserin,COc1cccc(c1OC)C(C1CCN(CC1)CCc1ccc(cc1)F)O,Hs,Antagonist,6.5 – 9.3,pIC50
serotonin_5ht2a,antagonists,H05,CN(CCC(c1ccc(cc1)F)Oc1cccc2c1OCO2)C,Hs,Antagonist,7.2,pIC50
serotonin_5ht2a,antagonists,[18F]altanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=S)[nH]c2c(c1=O)cccc2,Hs,Antagonist,-,-
serotonin_5ht2a,antagonists,[11C]volinanserin,COc1cccc(c1OC)C(C1CCN(CC1)CCc1ccc(cc1)F)O,Hs,Antagonist,-,-
serotonin_5ht2b,agonists,[3H]LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,8.7,pKd
serotonin_5ht2b,agonists,[3H]5-HT,NCCc1c[nH]c2c1cc(O)cc2,Rn,Full agonist,8.1,pKd
serotonin_5ht2b,agonists,[125I]DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.6 – 7.7,pKd
serotonin_5ht2b,agonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Hs,Partial agonist,9.3,pKi
serotonin_5ht2b,agonists,(+)-LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,9.0,pKi
serotonin_5ht2b,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,8.9,pKi
serotonin_5ht2b,agonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Partial agonist,8.0 – 9.4,pKi
serotonin_5ht2b,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Partial agonist,8.5 – 8.9,pKi
serotonin_5ht2b,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Biased agonist,8.4,pKi
serotonin_5ht2b,agonists,S 16924,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2,Hs,Full agonist,8.4,pKi
serotonin_5ht2b,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Rn,Full agonist,8.3,pKi
serotonin_5ht2b,agonists,AL-37350A,CC(Cc1c[nH]c2c1c1CCCOc1cc2)N,Hs,Full agonist,8.3,pKi
serotonin_5ht2b,agonists,Ro 60-0175,CC(Cn1ccc2c1cc(Cl)c(c2)F)N,Hs,Full agonist,8.3,pKi
serotonin_5ht2b,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Full agonist,8.2,pKi
serotonin_5ht2b,agonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Partial agonist,8.2,pKi
serotonin_5ht2b,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,7.9 – 8.4,pKi
serotonin_5ht2b,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,7.9 – 8.3,pKi
serotonin_5ht2b,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Rn,Full agonist,8.0,pKi
serotonin_5ht2b,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Rn,Full agonist,8.0,pKi
serotonin_5ht2b,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Rn,Full agonist,8.0,pKi
serotonin_5ht2b,agonists,(+)-norfenfluramine,CC(Cc1cccc(c1)C(F)(F)F)N,Hs,Full agonist,8.0,pKi
serotonin_5ht2b,agonists,BW723C86,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N,Hs,Full agonist,7.3 – 8.6,pKi
serotonin_5ht2b,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Hs,Partial agonist,7.4 – 8.5,pKi
serotonin_5ht2b,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Rn,Full agonist,7.8,pKi
serotonin_5ht2b,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.6 – 7.7,pKi
serotonin_5ht2b,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Rn,Partial agonist,7.6,pKi
serotonin_5ht2b,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Rn,Full agonist,7.6,pKi
serotonin_5ht2b,agonists,(+)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.6,pKi
serotonin_5ht2b,agonists,relenopride,COc1cc(N)c(cc1C(=O)NCC1CCN(CC1)CCC(c1ccc(cc1)F)OC(=O)N)Cl,Hs,Agonist,7.5,pKi
serotonin_5ht2b,agonists,(R)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.3 – 7.7,pKi
serotonin_5ht2b,agonists,brolamfetamine,COc1cc(Br)c(cc1CC(N)C)OC,Hs,Full agonist,7.4 – 7.6,pKi
serotonin_5ht2b,agonists,VER-3323,CC(CN1CCc2c1cc(Br)cc2)N,Hs,Full agonist,7.5,pKi
serotonin_5ht2b,agonists,dihydroergocryptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C,Hs,Biased agonist,7.5,pKi
serotonin_5ht2b,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,7.4,pKi
serotonin_5ht2b,agonists,ORG-37684,COc1ccc2c(c1OC1CNCC1)CCC2,Hs,Full agonist,7.4,pKi
serotonin_5ht2b,agonists,norfenfluramine,CC(Cc1cccc(c1)C(F)(F)F)N,Hs,Full agonist,7.3,pKi
serotonin_5ht2b,agonists,(-)-norfenfluramine,CC(Cc1cccc(c1)C(F)(F)F)N,Hs,Full agonist,7.3,pKi
serotonin_5ht2b,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,7.2,pKi
serotonin_5ht2b,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Rn,Full agonist,7.1,pKi
serotonin_5ht2b,agonists,quipazine,N1CCN(CC1)c1ccc2c(n1)cccc2,Hs,Full agonist,7.1,pKi
serotonin_5ht2b,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,7.0,pKi
serotonin_5ht2b,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Rn,Full agonist,7.0,pKi
serotonin_5ht2b,agonists,Org 12962,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F,Hs,Full agonist,7.0,pKi
serotonin_5ht2b,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,6.9,pKi
serotonin_5ht2b,agonists,quipazine,N1CCN(CC1)c1ccc2c(n1)cccc2,Rn,Full agonist,6.9,pKi
serotonin_5ht2b,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,6.7 – 6.9,pKi
serotonin_5ht2b,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Rn,Full agonist,6.8,pKi
serotonin_5ht2b,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,6.8,pKi
serotonin_5ht2b,agonists,2-methyl-5-HT,Cc1c(CCN)c2c([nH]1)ccc(c2)O,Rn,Full agonist,6.6,pKi
serotonin_5ht2b,agonists,MK-212,Clc1cncc(n1)N1CCNCC1,Hs,Full agonist,6.2 – 6.8,pKi
serotonin_5ht2b,agonists,MK-212,Clc1cncc(n1)N1CCNCC1,Rn,Full agonist,6.4,pKi
serotonin_5ht2b,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,6.2,pKi
serotonin_5ht2b,agonists,CGS-12066,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F,Hs,Full agonist,6.1,pKi
serotonin_5ht2b,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,5.8,pKi
serotonin_5ht2b,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,5.8,pKi
serotonin_5ht2b,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,5.8,pKi
serotonin_5ht2b,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,5.0 – 6.5,pKi
serotonin_5ht2b,agonists,pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Hs,Full agonist,5.7,pKi
serotonin_5ht2b,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.4,pKi
serotonin_5ht2b,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Rn,Full agonist,5.4,pKi
serotonin_5ht2b,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,6.0,pEC50
serotonin_5ht2b,antagonists,balovaptan,CN1Cc2cc(Cl)ccc2n2c(C1)nnc2C1CCC(CC1)Oc1ccccn1,Hs,Antagonist,11.6,pKd
serotonin_5ht2b,antagonists,[3H]rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,8.4,pKd
serotonin_5ht2b,antagonists,[3H]mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)CS(=O)(=O)N(C)C,Hs,Inverse agonist,7.9,pKd
serotonin_5ht2b,antagonists,BF-1,CCOc1ccc2c(c1)Sc1c(C2=C2CCN(CC2)C)c(OC)ccc1,Hs,Antagonist,10.1,pKi
serotonin_5ht2b,antagonists,RS-127445,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C,Hs,Antagonist,9.0 – 9.5,pKi
serotonin_5ht2b,antagonists,EGIS-7625,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-],Hs,Antagonist,9.0,pKi
serotonin_5ht2b,antagonists,LY53857,CC(C(O)C)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Hs,Antagonist,8.8 – 9.1,pKi
serotonin_5ht2b,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Antagonist,8.7 – 9.2,pKi
serotonin_5ht2b,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,8.7 – 9.2,pKi
serotonin_5ht2b,antagonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Antagonist,8.9,pKi
serotonin_5ht2b,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Antagonist,8.8,pKi
serotonin_5ht2b,antagonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Hs,Antagonist,8.4 – 9.0,pKi
serotonin_5ht2b,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Hs,Antagonist,8.5 – 8.8,pKi
serotonin_5ht2b,antagonists,SB 221284,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1,Hs,Antagonist,8.6,pKi
serotonin_5ht2b,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Antagonist,8.0 – 8.8,pKi
serotonin_5ht2b,antagonists,tegaserod,CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N,Hs,Antagonist,8.4,pKi
serotonin_5ht2b,antagonists,1-naphthylpiperazine,N1CCN(CC1)c1cccc2c1cccc2,Rn,Antagonist,8.3 – 8.4,pKi
serotonin_5ht2b,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Hs,Antagonist,7.9 – 8.8,pKi
serotonin_5ht2b,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Rn,Antagonist,8.3,pKi
serotonin_5ht2b,antagonists,SB 215505,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2,Hs,Antagonist,8.3,pKi
serotonin_5ht2b,antagonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Antagonist,8.2,pKi
serotonin_5ht2b,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Rn,Antagonist,8.2,pKi
serotonin_5ht2b,antagonists,LY53857,CC(C(O)C)OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C,Rn,Antagonist,8.2,pKi
serotonin_5ht2b,antagonists,rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.8 – 8.4,pKi
serotonin_5ht2b,antagonists,SB 206553,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1,Hs,Antagonist,7.6 – 8.5,pKi
serotonin_5ht2b,antagonists,SB 228357,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1,Hs,Antagonist,8.0 – 8.1,pKi
serotonin_5ht2b,antagonists,amesergide,O=C(C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1,Rn,Antagonist,8.0,pKi
serotonin_5ht2b,antagonists,LY86057,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O,Rn,Antagonist,7.9,pKi
serotonin_5ht2b,antagonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Antagonist,7.7,pKi
serotonin_5ht2b,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Hs,Antagonist,7.4 – 7.9,pKi
serotonin_5ht2b,antagonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Antagonist,7.5,pKi
serotonin_5ht2b,antagonists,rauwolscine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Rn,Antagonist,7.4,pKi
serotonin_5ht2b,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Rn,Antagonist,7.4,pKi
serotonin_5ht2b,antagonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Antagonist,7.3,pKi
serotonin_5ht2b,antagonists,yohimbine,COC(=O)C1C(O)CCC2C1CC1N(C2)CCc2c1[nH]c1c2cccc1,Rn,Antagonist,7.3,pKi
serotonin_5ht2b,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Rn,Antagonist,7.3,pKi
serotonin_5ht2b,antagonists,trazodone,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,Hs,Antagonist,7.1,pKi
serotonin_5ht2b,antagonists,SB 243213,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,7.0,pKi
serotonin_5ht2b,antagonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Antagonist,6.9,pKi
serotonin_5ht2b,antagonists,SB 242084,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,6.8 – 7.0,pKi
serotonin_5ht2b,antagonists,SB 204741,O=C(Nc1snc(c1)C)Nc1ccc2c(c1)ccn2C,Hs,Antagonist,6.9,pKi
serotonin_5ht2b,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,6.8,pKi
serotonin_5ht2b,antagonists,SDZ SER-082,CN1CCC2C(C1)c1cccc3c1N(C2)CC3,Hs,Antagonist,6.7,pKi
serotonin_5ht2b,antagonists,agomelatine,COc1ccc2c(c1)c(CCNC(=O)C)ccc2,Hs,Antagonist,6.6,pKi
serotonin_5ht2b,antagonists,sarpogrelate,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C,Hs,Antagonist,6.6,pKi
serotonin_5ht2b,antagonists,spiroxatrine,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1,Hs,Antagonist,6.3 – 6.8,pKi
serotonin_5ht2b,antagonists,piboserod,CCCCN1CCC(CC1)CNC(=O)c1c2OCCCn2c2c1cccc2,Hs,Antagonist,6.3 – 6.6,pKi
serotonin_5ht2b,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,6.1 – 6.7,pKi
serotonin_5ht2b,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.9 – 6.5,pKi
serotonin_5ht2b,antagonists,"L-741,626",Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,Hs,Antagonist,6.2,pKi
serotonin_5ht2b,antagonists,haloperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,Hs,Antagonist,5.8 – 6.4,pKi
serotonin_5ht2b,antagonists,RS-102221,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F,Hs,Antagonist,6.0 – 6.1,pKi
serotonin_5ht2b,antagonists,spiramide,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,6.0,pKi
serotonin_5ht2b,antagonists,volinanserin,COc1cccc(c1OC)C(C1CCN(CC1)CCc1ccc(cc1)F)O,Hs,Antagonist,6.0,pKi
serotonin_5ht2b,antagonists,piribedil,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2,Hs,Antagonist,5.9,pKi
serotonin_5ht2b,antagonists,SB 224289,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,5.9,pKi
serotonin_5ht2b,antagonists,SB 277011-A,N#Cc1ccc2c(c1)CCN(C2)CCC1CCC(CC1)NC(=O)c1ccnc2c1cccc2,Hs,Antagonist,5.9,pKi
serotonin_5ht2b,antagonists,pindolol,OC(COc1cccc2c1cc[nH]2)CNC(C)C,Hs,Antagonist,5.7,pKi
serotonin_5ht2b,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Rn,Antagonist,5.5,pKi
serotonin_5ht2b,antagonists,glemanserin,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1,Hs,Antagonist,5.5,pKi
serotonin_5ht2b,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Rn,Antagonist,5.4,pKi
serotonin_5ht2b,antagonists,fluoxetine,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Hs,Antagonist,5.3,pKi
serotonin_5ht2b,antagonists,norfluoxetine,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Hs,Antagonist,5.3,pKi
serotonin_5ht2b,antagonists,melatonin,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2,Hs,Antagonist,5.2,pKi
serotonin_5ht2c,agonists,[125I]DOI,COc1cc(I)c(cc1CC(N)C)OC,Rn,Full agonist,9.1,pKd
serotonin_5ht2c,agonists,[125I]DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,8.7 – 9.0,pKd
serotonin_5ht2c,agonists,YM348,CCc1oc2c(c1)c1c(cc2)cnn1CC(N)C,Hs,Full agonist,9.0,pKi
serotonin_5ht2c,agonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Partial agonist,8.7,pKi
serotonin_5ht2c,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Hs,Partial agonist,8.7,pKi
serotonin_5ht2c,agonists,(+)-LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,8.2 – 9.0,pKi
serotonin_5ht2c,agonists,AL-37350A,CC(Cc1c[nH]c2c1c1CCCOc1cc2)N,Hs,Full agonist,8.5,pKi
serotonin_5ht2c,agonists,Lysergide,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Full agonist,8.2 – 8.6,pKi
serotonin_5ht2c,agonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Hs,Full agonist,8.3,pKi
serotonin_5ht2c,agonists,VER-3323,CC(CN1CCc2c1cc(Br)cc2)N,Hs,Full agonist,8.2,pKi
serotonin_5ht2c,agonists,lisuride,CCN(C(=O)NC1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Partial agonist,7.9 – 8.3,pKi
serotonin_5ht2c,agonists,(+)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,8.1,pKi
serotonin_5ht2c,agonists,ORG-37684,COc1ccc2c(c1OC1CNCC1)CCC2,Hs,Full agonist,8.1,pKi
serotonin_5ht2c,agonists,(R)-DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.4 – 8.7,pKi
serotonin_5ht2c,agonists,Ro 60-0175,CC(Cn1ccc2c1cc(Cl)c(c2)F)N,Hs,Full agonist,7.7 – 8.2,pKi
serotonin_5ht2c,agonists,DOI,COc1cc(I)c(cc1CC(N)C)OC,Hs,Full agonist,7.2 – 8.6,pKi
serotonin_5ht2c,agonists,ergotamine,O=C(C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)NC1(C)OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O,Rn,Partial agonist,7.9,pKi
serotonin_5ht2c,agonists,methylergonovine,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CO,Rn,Full agonist,7.9,pKi
serotonin_5ht2c,agonists,brolamfetamine,COc1cc(Br)c(cc1CC(N)C)OC,Hs,Full agonist,6.8 – 8.9,pKi
serotonin_5ht2c,agonists,Org 12962,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F,Hs,Full agonist,7.8,pKi
serotonin_5ht2c,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,7.8,pKi
serotonin_5ht2c,agonists,α-methyl-5-HT,CC(Cc1c[nH]c2c1cc(O)cc2)N,Hs,Full agonist,6.9 – 8.6,pKi
serotonin_5ht2c,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Hs,Full agonist,6.8 – 8.6,pKi
serotonin_5ht2c,agonists,S 16924,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2,Hs,Full agonist,7.7,pKi
serotonin_5ht2c,agonists,aripiprazole,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,Hs,Partial agonist,7.6,pKi
serotonin_5ht2c,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Hs,Partial agonist,6.5 – 8.5,pKi
serotonin_5ht2c,agonists,WAY-163909,C1CC2C(C1)c1c3N2CCNCc3ccc1,Hs,Full agonist,6.7 – 8.0,pKi
serotonin_5ht2c,agonists,5-hydroxytryptamine,NCCc1c[nH]c2c1cc(O)cc2,Rn,Full agonist,6.7 – 7.9,pKi
serotonin_5ht2c,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Hs,Full agonist,6.7 – 7.8,pKi
serotonin_5ht2c,agonists,m-chlorophenylpiperazine,Clc1cccc(c1)N1CCNCC1,Rn,Partial agonist,7.2,pKi
serotonin_5ht2c,agonists,TFMPP,FC(c1cccc(c1)N1CCNCC1)(F)F,Hs,Full agonist,6.5 – 7.8,pKi
serotonin_5ht2c,agonists,GR 127935,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,7.0,pKi
serotonin_5ht2c,agonists,BW723C86,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N,Hs,Full agonist,6.9 – 7.1,pKi
serotonin_5ht2c,agonists,RU 24969,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1,Hs,Full agonist,6.8,pKi
serotonin_5ht2c,agonists,SB 216641,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Partial agonist,6.8,pKi
serotonin_5ht2c,agonists,quipazine,N1CCN(CC1)c1ccc2c(n1)cccc2,Hs,Full agonist,5.9 – 7.3,pKi
serotonin_5ht2c,agonists,5-MeO-DMT,COc1ccc2c(c1)c(CCN(C)C)c[nH]2,Hs,Full agonist,6.2 – 7.0,pKi
serotonin_5ht2c,agonists,brolamfetamine,COc1cc(Br)c(cc1CC(N)C)OC,Rn,Full agonist,6.6,pKi
serotonin_5ht2c,agonists,oxymetazoline,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C,Hs,Full agonist,6.3 – 6.8,pKi
serotonin_5ht2c,agonists,pergolide,CCCN1CC(CSC)CC2C1Cc1c[nH]c3c1c2ccc3,Hs,Partial agonist,6.5,pKi
serotonin_5ht2c,agonists,tryptamine,NCCc1c[nH]c2c1cccc2,Hs,Full agonist,5.6 – 7.2,pKi
serotonin_5ht2c,agonists,5-MeOT,NCCc1c[nH]c2c1cc(OC)cc2,Rn,Full agonist,6.3,pKi
serotonin_5ht2c,agonists,MK-212,Clc1cncc(n1)N1CCNCC1,Hs,Full agonist,5.6 – 7.0,pKi
serotonin_5ht2c,agonists,BRL-15572,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O,Hs,Partial agonist,6.2,pKi
serotonin_5ht2c,agonists,cabergoline,C=CCN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C,Hs,Full agonist,6.2,pKi
serotonin_5ht2c,agonists,bromocriptine,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,Hs,Partial agonist,6.1,pKi
serotonin_5ht2c,agonists,5-CT,NCCc1c[nH]c2c1cc(cc2)C(=O)N,Hs,Full agonist,5.2 – 6.7,pKi
serotonin_5ht2c,agonists,8-OH-DPAT,CCCN(C1CCc2c(C1)c(O)ccc2)CCC,Hs,Full agonist,5.6,pKi
serotonin_5ht2c,agonists,CGS-12066,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F,Hs,Full agonist,5.6,pKi
serotonin_5ht2c,agonists,LY344864,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C,Hs,Full agonist,5.5,pKi
serotonin_5ht2c,agonists,capeserod,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1,Hs,Partial agonist,5.3,pKi
serotonin_5ht2c,agonists,quinpirole,CCCN1CCCC2C1Cc1cn[nH]c1C2,Hs,Full agonist,5.0 – 5.5,pKi
serotonin_5ht2c,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Full agonist,8.1,pEC50
serotonin_5ht2c,agonists,lorcaserin,Clc1ccc2c(c1)C(C)CNCC2,Hs,Agonist,8.2,pIC50
serotonin_5ht2c,agonists,[3H]LSD,CCN(C(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Agonist,-,-
serotonin_5ht2c,antagonists,[3H]mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)CS(=O)(=O)N(C)C,Hs,Inverse agonist,8.7 – 9.3,pKd
serotonin_5ht2c,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Rn,Antagonist,9.3,pKi
serotonin_5ht2c,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Rn,Inverse agonist,9.2,pKi
serotonin_5ht2c,antagonists,sertindole,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O,Hs,Inverse agonist,9.0 – 9.2,pKi
serotonin_5ht2c,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Rn,Antagonist,8.8 – 9.4,pKi
serotonin_5ht2c,antagonists,SB 228357,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1,Hs,Antagonist,9.0 – 9.1,pKi
serotonin_5ht2c,antagonists,mesulergine,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C,Hs,Inverse agonist,8.7 – 9.3,pKi
serotonin_5ht2c,antagonists,FR260010,Cc1ncn(c1)c1cccc(c1)Nc1ncnc2c1CCc1c2cccc1,Hs,Antagonist,9.0,pKi
serotonin_5ht2c,antagonists,ritanserin,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F,Hs,Antagonist,8.2 – 9.6,pKi
serotonin_5ht2c,antagonists,methysergide,CCC(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)cn3C)CO,Hs,Antagonist,8.6 – 9.1,pKi
serotonin_5ht2c,antagonists,metergoline,O=C(OCc1ccccc1)NCC1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C,Hs,Inverse agonist,8.8,pKi
serotonin_5ht2c,antagonists,mianserin,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1,Hs,Inverse agonist,8.3 – 9.2,pKi
serotonin_5ht2c,antagonists,SB 221284,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1,Hs,Antagonist,8.7,pKi
serotonin_5ht2c,antagonists,amoxapine,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1,Rn,Antagonist,8.7,pKi
serotonin_5ht2c,antagonists,zotepine,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Inverse agonist,8.6,pKi
serotonin_5ht2c,antagonists,SB 242084,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,8.2 – 9.0,pKi
serotonin_5ht2c,antagonists,ziprasidone,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2,Hs,Inverse agonist,7.9 – 9.0,pKi
serotonin_5ht2c,antagonists,methiothepin,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C,Hs,Inverse agonist,8.4,pKi
serotonin_5ht2c,antagonists,RS-102221,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F,Rn,Antagonist,8.4,pKi
serotonin_5ht2c,antagonists,RS-102221,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F,Hs,Antagonist,8.3 – 8.4,pKi
serotonin_5ht2c,antagonists,tiospirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2,Hs,Inverse agonist,8.3,pKi
serotonin_5ht2c,antagonists,olanzapine,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C,Hs,Inverse agonist,8.1 – 8.4,pKi
serotonin_5ht2c,antagonists,SDZ SER-082,CN1CCC2C(C1)c1cccc3c1N(C2)CC3,Hs,Antagonist,8.1,pKi
serotonin_5ht2c,antagonists,amitriptyline,CN(CCC=C1c2ccccc2CCc2c1cccc2)C,Rn,Antagonist,8.1,pKi
serotonin_5ht2c,antagonists,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,Hs,Inverse agonist,7.4 – 8.7,pKi
serotonin_5ht2c,antagonists,cyamemazine,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1,Hs,Antagonist,7.9,pKi
serotonin_5ht2c,antagonists,loxapine,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2,Hs,Inverse agonist,7.8 – 8.0,pKi
serotonin_5ht2c,antagonists,chlorpromazine,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,Hs,Antagonist,7.6 – 8.2,pKi
serotonin_5ht2c,antagonists,SB 206553,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1,Hs,Antagonist,7.8 – 7.9,pKi
serotonin_5ht2c,antagonists,EGIS-7625,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-],Hs,Antagonist,7.7,pKi
serotonin_5ht2c,antagonists,SB 215505,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2,Hs,Antagonist,7.7,pKi
serotonin_5ht2c,antagonists,volinanserin,COc1cccc(c1OC)C(C1CCN(CC1)CCc1ccc(cc1)F)O,Hs,Antagonist,7.5 – 7.7,pKi
serotonin_5ht2c,antagonists,risperidone,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,Hs,Inverse agonist,7.5 – 7.6,pKi
serotonin_5ht2c,antagonists,mirtazapine,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1,Hs,Antagonist,7.4,pKi
serotonin_5ht2c,antagonists,xanomeline,CCCCCCOc1nsnc1C1=CCCN(C1)C,Hs,Antagonist,7.4,pKi
serotonin_5ht2c,antagonists,sarpogrelate,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C,Hs,Antagonist,7.4,pKi
serotonin_5ht2c,antagonists,terguride,CCN(C(=O)NC1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)CC,Hs,Antagonist,7.3,pKi
serotonin_5ht2c,antagonists,fluoxetine,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Rn,Antagonist,7.3,pKi
serotonin_5ht2c,antagonists,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,Hs,Antagonist,7.2 – 7.3,pKi
serotonin_5ht2c,antagonists,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2,Hs,Antagonist,6.8 – 7.5,pKi
serotonin_5ht2c,antagonists,S33084,N#Cc1ccc2c(c1)C1CN(CC1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1,Hs,Antagonist,7.1,pKi
serotonin_5ht2c,antagonists,apomorphine,CN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O,Hs,Antagonist,7.0,pKi
serotonin_5ht2c,antagonists,LY334362,NC(=NN=Cc1cccc(c1)OCc1ccc(cc1)C(=O)c1ccccc1)N,Hs,Antagonist,7.0,pKi
serotonin_5ht2c,antagonists,perphenazine,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2,Hs,Antagonist,6.9,pKi
serotonin_5ht2c,antagonists,glemanserin,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1,Hs,Antagonist,6.6,pKi
serotonin_5ht2c,antagonists,trazodone,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,Hs,Antagonist,6.6,pKi
serotonin_5ht2c,antagonists,idalopirdine,Fc1ccc2c(c1)[nH]cc2CCNCc1cccc(c1)OCC(C(F)F)(F)F,Hs,Antagonist,6.6,pKi
serotonin_5ht2c,antagonists,trazodone,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,Rn,Antagonist,6.4 – 6.7,pKi
serotonin_5ht2c,antagonists,roxindole,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,Hs,Antagonist,6.5,pKi
serotonin_5ht2c,antagonists,norfluoxetine,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,Rn,Antagonist,6.5,pKi
serotonin_5ht2c,antagonists,trifluoperazine,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,Hs,Antagonist,6.4,pKi
serotonin_5ht2c,antagonists,mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C,Hs,Antagonist,6.4,pKi
serotonin_5ht2c,antagonists,RS-127445,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C,Hs,Antagonist,6.3,pKi
serotonin_5ht2c,antagonists,MPDT,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1,Rn,Antagonist,6.2,pKi
serotonin_5ht2c,antagonists,agomelatine,COc1ccc2c(c1)c(CCNC(=O)C)ccc2,Hs,Antagonist,6.2,pKi
serotonin_5ht2c,antagonists,duloxetine,CNCCC(c1cccs1)Oc1cccc2c1cccc2,Hs,Antagonist,6.0,pKi
serotonin_5ht2c,antagonists,SB 224289,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C,Hs,Antagonist,5.7 – 6.2,pKi
serotonin_5ht2c,antagonists,spiperone,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.6 – 6.2,pKi
serotonin_5ht2c,antagonists,spiramide,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,Hs,Antagonist,5.8,pKi
serotonin_5ht2c,antagonists,SB 204741,O=C(Nc1snc(c1)C)Nc1ccc2c(c1)ccn2C,Hs,Antagonist,5.6,pKi
serotonin_5ht2c,antagonists,AC-90179,COc1ccc(cc1)CC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)C,Hs,Inverse agonist,5.5,pKi
serotonin_5ht2c,antagonists,SB 243213,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C,Hs,Antagonist,9.0,pEC50
